Billing and Coding: Controlled Substance Monitoring and Drugs of Abuse Testing (A56645)


Related Local Coverage Determination (LCD)
L35006-Controlled Substance Monitoring and Drugs of Abuse Testing


Contractor NameContract NumberStates
Novitas Solutions, Inc. 04111 - A and B MAC Colorado
04112 - A and B MAC Colorado
04211 - A and B MAC New Mexico
04212 - A and B MAC New Mexico
04311 - A and B MAC Oklahoma
04312 - A and B MAC Oklahoma
04411 - A and B MAC Texas
04412 - A and B MAC Texas
04911 - A and B MAC Colorado
New Mexico
Oklahoma
Texas
07101 - A and B MAC Arkansas
07102 - A and B MAC Arkansas
07201 - A and B MAC Louisiana
07202 - A and B MAC Louisiana
07301 - A and B MAC Mississippi
07302 - A and B MAC Mississippi
12101 - A and B MAC Delaware
12102 - A and B MAC Delaware
12201 - A and B MAC District of Columbia
12202 - A and B MAC District of Columbia
12301 - A and B MAC Maryland
12302 - A and B MAC Maryland
12401 - A and B MAC New Jersey
12402 - A and B MAC New Jersey
12501 - A and B MAC Pennsylvania
12502 - A and B MAC Pennsylvania
12901 - A and B MAC Delaware
District of Columbia
Maryland
New Jersey
Pennsylvania

Article Information

Article ID Number: A56645 Status: A-Approved

Article Title: Billing and Coding: Controlled Substance Monitoring and Drugs of Abuse Testing

Original Article Effective Date: 06/27/2019

Revision Effective Date: 10/01/2021

Article Text:

This Billing and Coding Article provides billing and coding guidance for Local Coverage Determination (LCD) L35006, Controlled Substance Monitoring and Drugs of Abuse Testing. Please refer to the LCD for reasonable and necessary requirements and limitations.

Coding Guidance:

Notice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. When billing for non-covered services, use the appropriate modifier.

Utilization Parameters

Consistent with the related LCD:

  1. It is not appropriate to report more than twelve (12) presumptive UDT testing (CPT code 80305, 80306, or 80307) testing services per calendar year.
    • As stated in the related LCD, an exception will be made for patients with documented diagnoses consistent with a substance abuse disorder (SUD). It is not appropriate to report more than three (3) presumptive UDT tests (80305, 80306, or 80307) in seven (7) days when billed with any of the ICD-10 codes noted in ICD-10 Group 1 Paragraph.
  2. It is not appropriate to report more than twelve (12) definitive UDT testing services (CPT/HCPCS code G0480, G0481, G0482, G0483, or G0659) per calendar year for chronic opioid therapy (COT), as noted in ICD-10 Group 2 Paragraph. Refer to the related LCD for more information.
  3. It is not appropriate to report more than one (1) presumptive test result per patient per date of service regardless of the number of billing providers.

Documentation Requirements

Note
: Refer to the LCD for documentation requirements, in the patient’s medical record, of medical necessity for testing ordered on an individual patient basis by the clinician.

  1. All documentation must be maintained in the patient's medical record and made available to the contractor upon request.
  2. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient.
  3. The submitted medical record must support the use of the selected ICD-10-CM code(s). The submitted CPT/HCPCS code must describe the service performed.

Coding Information
Bill Type Codes:

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.

12Hospital Inpatient (Medicare Part B only)
13Hospital Outpatient
14Hospital - Laboratory Services Provided to Non-patients
22Skilled Nursing - Inpatient (Medicare Part B only)
23Skilled Nursing - Outpatient
71Clinic - Rural Health
72Clinic - Hospital Based or Independent Renal Dialysis Center
73Clinic - Freestanding
77Clinic - Federally Qualified Health Center (FQHC)
85Critical Access Hospital

Revenue Codes:

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.

0300 Laboratory - General Classification
0301 Laboratory - Chemistry
0309 Laboratory - Other Laboratory
0971 Professional Fees - Laboratory

CPT/HCPCS Codes:

Group 1 Paragraph:

Note: Providers are reminded to refer to the long descriptors of the CPT codes in their CPT book.

Presumptive UDT



Group 1 CPT Codes:
80305 DRUG TEST(S), PRESUMPTIVE, ANY NUMBER OF DRUG CLASSES, ANY NUMBER OF DEVICES OR PROCEDURES; CAPABLE OF BEING READ BY DIRECT OPTICAL OBSERVATION ONLY (EG, UTILIZING IMMUNOASSAY [EG, DIPSTICKS, CUPS, CARDS, OR CARTRIDGES]), INCLUDES SAMPLE VALIDATION WHEN PERFORMED, PER DATE OF SERVICE
80306 DRUG TEST(S), PRESUMPTIVE, ANY NUMBER OF DRUG CLASSES, ANY NUMBER OF DEVICES OR PROCEDURES; READ BY INSTRUMENT ASSISTED DIRECT OPTICAL OBSERVATION (EG, UTILIZING IMMUNOASSAY [EG, DIPSTICKS, CUPS, CARDS, OR CARTRIDGES]), INCLUDES SAMPLE VALIDATION WHEN PERFORMED, PER DATE OF SERVICE
80307 DRUG TEST(S), PRESUMPTIVE, ANY NUMBER OF DRUG CLASSES, ANY NUMBER OF DEVICES OR PROCEDURES; BY INSTRUMENT CHEMISTRY ANALYZERS (EG, UTILIZING IMMUNOASSAY [EG, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), CHROMATOGRAPHY (EG, GC, HPLC), AND MASS SPECTROMETRY EITHER WITH OR WITHOUT CHROMATOGRAPHY, (EG, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) INCLUDES SAMPLE VALIDATION WHEN PERFORMED, PER DATE OF SERVICE


Group 2 Paragraph:

Definitive UDT



Group 2 CPT Codes:
G0480 DRUG TEST(S), DEFINITIVE, UTILIZING (1) DRUG IDENTIFICATION METHODS ABLE TO IDENTIFY INDIVIDUAL DRUGS AND DISTINGUISH BETWEEN STRUCTURAL ISOMERS (BUT NOT NECESSARILY STEREOISOMERS), INCLUDING, BUT NOT LIMITED TO GC/MS (ANY TYPE, SINGLE OR TANDEM) AND LC/MS (ANY TYPE, SINGLE OR TANDEM AND EXCLUDING IMMUNOASSAYS (E.G., IA, EIA, ELISA, EMIT, FPIA) AND ENZYMATIC METHODS (E.G., ALCOHOL DEHYDROGENASE)), (2) STABLE ISOTOPE OR OTHER UNIVERSALLY RECOGNIZED INTERNAL STANDARDS IN ALL SAMPLES (E.G., TO CONTROL FOR MATRIX EFFECTS, INTERFERENCES AND VARIATIONS IN SIGNAL STRENGTH), AND (3) METHOD OR DRUG-SPECIFIC CALIBRATION AND MATRIX-MATCHED QUALITY CONTROL MATERIAL (E.G., TO CONTROL FOR INSTRUMENT VARIATIONS AND MASS SPECTRAL DRIFT); QUALITATIVE OR QUANTITATIVE, ALL SOURCES, INCLUDES SPECIMEN VALIDITY TESTING, PER DAY; 1-7 DRUG CLASS(ES), INCLUDING METABOLITE(S) IF PERFORMED
G0481 DRUG TEST(S), DEFINITIVE, UTILIZING (1) DRUG IDENTIFICATION METHODS ABLE TO IDENTIFY INDIVIDUAL DRUGS AND DISTINGUISH BETWEEN STRUCTURAL ISOMERS (BUT NOT NECESSARILY STEREOISOMERS), INCLUDING, BUT NOT LIMITED TO GC/MS (ANY TYPE, SINGLE OR TANDEM) AND LC/MS (ANY TYPE, SINGLE OR TANDEM AND EXCLUDING IMMUNOASSAYS (E.G., IA, EIA, ELISA, EMIT, FPIA) AND ENZYMATIC METHODS (E.G., ALCOHOL DEHYDROGENASE)), (2) STABLE ISOTOPE OR OTHER UNIVERSALLY RECOGNIZED INTERNAL STANDARDS IN ALL SAMPLES (E.G., TO CONTROL FOR MATRIX EFFECTS, INTERFERENCES AND VARIATIONS IN SIGNAL STRENGTH), AND (3) METHOD OR DRUG-SPECIFIC CALIBRATION AND MATRIX-MATCHED QUALITY CONTROL MATERIAL (E.G., TO CONTROL FOR INSTRUMENT VARIATIONS AND MASS SPECTRAL DRIFT); QUALITATIVE OR QUANTITATIVE, ALL SOURCES, INCLUDES SPECIMEN VALIDITY TESTING, PER DAY; 8-14 DRUG CLASS(ES), INCLUDING METABOLITE(S) IF PERFORMED
G0482 DRUG TEST(S), DEFINITIVE, UTILIZING (1) DRUG IDENTIFICATION METHODS ABLE TO IDENTIFY INDIVIDUAL DRUGS AND DISTINGUISH BETWEEN STRUCTURAL ISOMERS (BUT NOT NECESSARILY STEREOISOMERS), INCLUDING, BUT NOT LIMITED TO GC/MS (ANY TYPE, SINGLE OR TANDEM) AND LC/MS (ANY TYPE, SINGLE OR TANDEM AND EXCLUDING IMMUNOASSAYS (E.G., IA, EIA, ELISA, EMIT, FPIA) AND ENZYMATIC METHODS (E.G., ALCOHOL DEHYDROGENASE)), (2) STABLE ISOTOPE OR OTHER UNIVERSALLY RECOGNIZED INTERNAL STANDARDS IN ALL SAMPLES (E.G., TO CONTROL FOR MATRIX EFFECTS, INTERFERENCES AND VARIATIONS IN SIGNAL STRENGTH), AND (3) METHOD OR DRUG-SPECIFIC CALIBRATION AND MATRIX-MATCHED QUALITY CONTROL MATERIAL (E.G., TO CONTROL FOR INSTRUMENT VARIATIONS AND MASS SPECTRAL DRIFT); QUALITATIVE OR QUANTITATIVE, ALL SOURCES, INCLUDES SPECIMEN VALIDITY TESTING, PER DAY; 15-21 DRUG CLASS(ES), INCLUDING METABOLITE(S) IF PERFORMED
G0483 DRUG TEST(S), DEFINITIVE, UTILIZING (1) DRUG IDENTIFICATION METHODS ABLE TO IDENTIFY INDIVIDUAL DRUGS AND DISTINGUISH BETWEEN STRUCTURAL ISOMERS (BUT NOT NECESSARILY STEREOISOMERS), INCLUDING, BUT NOT LIMITED TO GC/MS (ANY TYPE, SINGLE OR TANDEM) AND LC/MS (ANY TYPE, SINGLE OR TANDEM AND EXCLUDING IMMUNOASSAYS (E.G., IA, EIA, ELISA, EMIT, FPIA) AND ENZYMATIC METHODS (E.G., ALCOHOL DEHYDROGENASE)), (2) STABLE ISOTOPE OR OTHER UNIVERSALLY RECOGNIZED INTERNAL STANDARDS IN ALL SAMPLES (E.G., TO CONTROL FOR MATRIX EFFECTS, INTERFERENCES AND VARIATIONS IN SIGNAL STRENGTH), AND (3) METHOD OR DRUG-SPECIFIC CALIBRATION AND MATRIX-MATCHED QUALITY CONTROL MATERIAL (E.G., TO CONTROL FOR INSTRUMENT VARIATIONS AND MASS SPECTRAL DRIFT); QUALITATIVE OR QUANTITATIVE, ALL SOURCES, INCLUDES SPECIMEN VALIDITY TESTING, PER DAY; 22 OR MORE DRUG CLASS(ES), INCLUDING METABOLITE(S) IF PERFORMED
G0659 DRUG TEST(S), DEFINITIVE, UTILIZING DRUG IDENTIFICATION METHODS ABLE TO IDENTIFY INDIVIDUAL DRUGS AND DISTINGUISH BETWEEN STRUCTURAL ISOMERS (BUT NOT NECESSARILY STEREOISOMERS), INCLUDING BUT NOT LIMITED TO GC/MS (ANY TYPE, SINGLE OR TANDEM) AND LC/MS (ANY TYPE, SINGLE OR TANDEM), EXCLUDING IMMUNOASSAYS (E.G., IA, EIA, ELISA, EMIT, FPIA) AND ENZYMATIC METHODS (E.G., ALCOHOL DEHYDROGENASE), PERFORMED WITHOUT METHOD OR DRUG-SPECIFIC CALIBRATION, WITHOUT MATRIX-MATCHED QUALITY CONTROL MATERIAL, OR WITHOUT USE OF STABLE ISOTOPE OR OTHER UNIVERSALLY RECOGNIZED INTERNAL STANDARD(S) FOR EACH DRUG, DRUG METABOLITE OR DRUG CLASS PER SPECIMEN; QUALITATIVE OR QUANTITATIVE, ALL SOURCES, INCLUDES SPECIMEN VALIDITY TESTING, PER DAY, ANY NUMBER OF DRUG CLASSES


ICD-10 Codes That Are Covered

It is the provider’s responsibility to select codes carried out to the highest level of specificity and selected from the ICD-10-CM code book appropriate to the year in which the service is rendered for the claim(s) submitted. 

Physicians are to select the most appropriate diagnosis code. Labs are not to prepopulate requisition forms with diagnosis codes. 

The following ICD-10-CM codes support medical necessity and provide coverage for CPT codes: 80305, 80306, and 80307 (Presumptive UDT)

E87.2 Acidosis
F10.120 Alcohol abuse with intoxication, uncomplicated
F11.20 Opioid dependence, uncomplicated
F12.120 Cannabis abuse with intoxication, uncomplicated
F12.220 Cannabis dependence with intoxication, uncomplicated
F13.120 Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated
F14.120 Cocaine abuse with intoxication, uncomplicated
F14.220 Cocaine dependence with intoxication, uncomplicated
F16.120 Hallucinogen abuse with intoxication, uncomplicated
F18.10 Inhalant abuse, uncomplicated
F18.120 Inhalant abuse with intoxication, uncomplicated
F18.90 Inhalant use, unspecified, uncomplicated
F19.20 Other psychoactive substance dependence, uncomplicated
F20.0 Paranoid schizophrenia
F20.1 Disorganized schizophrenia
F20.2 Catatonic schizophrenia
F20.89 Other schizophrenia
F55.3 Abuse of steroids or hormones
F55.4 Abuse of vitamins
F55.8 Abuse of other non-psychoactive substances
G40.301 Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus
G40.309 Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus
G40.311 Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus
G40.319 Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus
G40.901 Epilepsy, unspecified, not intractable, with status epilepticus
G40.909 Epilepsy, unspecified, not intractable, without status epilepticus
G40.911 Epilepsy, unspecified, intractable, with status epilepticus
G40.919 Epilepsy, unspecified, intractable, without status epilepticus
I44.0 Atrioventricular block, first degree
I44.1 Atrioventricular block, second degree
I44.30 Unspecified atrioventricular block
I45.81 Long QT syndrome
I47.1 Supraventricular tachycardia
I47.2 Ventricular tachycardia
M25.50 Pain in unspecified joint
M25.59 Pain in other specified joint
M47.811 Spondylosis without myelopathy or radiculopathy, occipito-atlanto-axial region
M47.812 Spondylosis without myelopathy or radiculopathy, cervical region
M47.813 Spondylosis without myelopathy or radiculopathy, cervicothoracic region
M47.816 Spondylosis without myelopathy or radiculopathy, lumbar region
M47.817 Spondylosis without myelopathy or radiculopathy, lumbosacral region
M47.818 Spondylosis without myelopathy or radiculopathy, sacral and sacrococcygeal region
M51.14 Intervertebral disc disorders with radiculopathy, thoracic region
M51.15 Intervertebral disc disorders with radiculopathy, thoracolumbar region
M51.16 Intervertebral disc disorders with radiculopathy, lumbar region
M51.17 Intervertebral disc disorders with radiculopathy, lumbosacral region
M51.36 Other intervertebral disc degeneration, lumbar region
M51.37 Other intervertebral disc degeneration, lumbosacral region
M54.10 Radiculopathy, site unspecified
M54.14 Radiculopathy, thoracic region
M54.15 Radiculopathy, thoracolumbar region
M54.16 Radiculopathy, lumbar region
M54.17 Radiculopathy, lumbosacral region
M54.18 Radiculopathy, sacral and sacrococcygeal region
M54.2 Cervicalgia
M54.50 Low back pain, unspecified
M54.51 Vertebrogenic low back pain
M54.59 Other low back pain
M60.811 Other myositis, right shoulder
M60.812 Other myositis, left shoulder
M60.821 Other myositis, right upper arm
M60.822 Other myositis, left upper arm
M60.831 Other myositis, right forearm
M60.832 Other myositis, left forearm
M60.841 Other myositis, right hand
M60.842 Other myositis, left hand
M60.851 Other myositis, right thigh
M60.852 Other myositis, left thigh
M60.861 Other myositis, right lower leg
M60.862 Other myositis, left lower leg
M60.871 Other myositis, right ankle and foot
M60.872 Other myositis, left ankle and foot
M60.88 Other myositis, other site
M60.89 Other myositis, multiple sites
M79.11 Myalgia of mastication muscle
M79.12 Myalgia of auxiliary muscles, head and neck
M79.18 Myalgia, other site
M79.2 Neuralgia and neuritis, unspecified
M79.7 Fibromyalgia
R40.0 Somnolence
R40.1 Stupor
R40.2111 Coma scale, eyes open, never, in the field [EMT or ambulance]
R40.2112 Coma scale, eyes open, never, at arrival to emergency department
R40.2113 Coma scale, eyes open, never, at hospital admission
R40.2114 Coma scale, eyes open, never, 24 hours or more after hospital admission
R40.2121 Coma scale, eyes open, to pain, in the field [EMT or ambulance]
R40.2122 Coma scale, eyes open, to pain, at arrival to emergency department
R40.2123 Coma scale, eyes open, to pain, at hospital admission
R40.2124 Coma scale, eyes open, to pain, 24 hours or more after hospital admission
R40.2211 Coma scale, best verbal response, none, in the field [EMT or ambulance]
R40.2212 Coma scale, best verbal response, none, at arrival to emergency department
R40.2213 Coma scale, best verbal response, none, at hospital admission
R40.2214 Coma scale, best verbal response, none, 24 hours or more after hospital admission
R40.2221 Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance]
R40.2222 Coma scale, best verbal response, incomprehensible words, at arrival to emergency department
R40.2223 Coma scale, best verbal response, incomprehensible words, at hospital admission
R40.2224 Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admission
R40.2311 Coma scale, best motor response, none, in the field [EMT or ambulance]
R40.2312 Coma scale, best motor response, none, at arrival to emergency department
R40.2313 Coma scale, best motor response, none, at hospital admission
R40.2314 Coma scale, best motor response, none, 24 hours or more after hospital admission
R40.2321 Coma scale, best motor response, extension, in the field [EMT or ambulance]
R40.2322 Coma scale, best motor response, extension, at arrival to emergency department
R40.2323 Coma scale, best motor response, extension, at hospital admission
R40.2324 Coma scale, best motor response, extension, 24 hours or more after hospital admission
R40.2341 Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance]
R40.2342 Coma scale, best motor response, flexion withdrawal, at arrival to emergency department
R40.2343 Coma scale, best motor response, flexion withdrawal, at hospital admission
R40.2344 Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission
R40.2410 Glasgow coma scale score 13-15, unspecified time
R40.2411 Glasgow coma scale score 13-15, in the field [EMT or ambulance]
R40.2412 Glasgow coma scale score 13-15, at arrival to emergency department
R40.2413 Glasgow coma scale score 13-15, at hospital admission
R40.2414 Glasgow coma scale score 13-15, 24 hours or more after hospital admission
R40.2420 Glasgow coma scale score 9-12, unspecified time
R40.2421 Glasgow coma scale score 9-12, in the field [EMT or ambulance]
R40.2422 Glasgow coma scale score 9-12, at arrival to emergency department
R40.2423 Glasgow coma scale score 9-12, at hospital admission
R40.2424 Glasgow coma scale score 9-12, 24 hours or more after hospital admission
R40.2430 Glasgow coma scale score 3-8, unspecified time
R40.2431 Glasgow coma scale score 3-8, in the field [EMT or ambulance]
R40.2432 Glasgow coma scale score 3-8, at arrival to emergency department
R40.2433 Glasgow coma scale score 3-8, at hospital admission
R40.2434 Glasgow coma scale score 3-8, 24 hours or more after hospital admission
R40.2440 Other coma, without documented Glasgow coma scale score, or with partial score reported, unspecified time
R40.2441 Other coma, without documented Glasgow coma scale score, or with partial score reported, in the field [EMT or ambulance]
R40.2442 Other coma, without documented Glasgow coma scale score, or with partial score reported, at arrival to emergency department
R40.2443 Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission
R40.2444 Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission
R41.0 Disorientation, unspecified
R41.82 Altered mental status, unspecified
R44.0 Auditory hallucinations
R44.3 Hallucinations, unspecified
R56.9 Unspecified convulsions
T39.011A Poisoning by aspirin, accidental (unintentional), initial encounter
T39.012A Poisoning by aspirin, intentional self-harm, initial encounter
T39.013A Poisoning by aspirin, assault, initial encounter
T39.014A Poisoning by aspirin, undetermined, initial encounter
T39.091A Poisoning by salicylates, accidental (unintentional), initial encounter
T39.092A Poisoning by salicylates, intentional self-harm, initial encounter
T39.093A Poisoning by salicylates, assault, initial encounter
T39.094A Poisoning by salicylates, undetermined, initial encounter
T39.1X1A Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter
T39.1X2A Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter
T39.1X3A Poisoning by 4-Aminophenol derivatives, assault, initial encounter
T39.1X4A Poisoning by 4-Aminophenol derivatives, undetermined, initial encounter
T39.2X1A Poisoning by pyrazolone derivatives, accidental (unintentional), initial encounter
T39.2X2A Poisoning by pyrazolone derivatives, intentional self-harm, initial encounter
T39.2X3A Poisoning by pyrazolone derivatives, assault, initial encounter
T39.2X4A Poisoning by pyrazolone derivatives, undetermined, initial encounter
T39.311A Poisoning by propionic acid derivatives, accidental (unintentional), initial encounter
T39.312A Poisoning by propionic acid derivatives, intentional self-harm, initial encounter
T39.313A Poisoning by propionic acid derivatives, assault, initial encounter
T39.314A Poisoning by propionic acid derivatives, undetermined, initial encounter
T39.391A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), initial encounter
T39.392A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, initial encounter
T39.393A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, initial encounter
T39.394A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, initial encounter
T40.0X1A Poisoning by opium, accidental (unintentional), initial encounter
T40.0X2A Poisoning by opium, intentional self-harm, initial encounter
T40.0X3A Poisoning by opium, assault, initial encounter
T40.0X4A Poisoning by opium, undetermined, initial encounter
T40.1X1A Poisoning by heroin, accidental (unintentional), initial encounter
T40.1X2A Poisoning by heroin, intentional self-harm, initial encounter
T40.1X3A Poisoning by heroin, assault, initial encounter
T40.1X4A Poisoning by heroin, undetermined, initial encounter
T40.2X1A Poisoning by other opioids, accidental (unintentional), initial encounter
T40.2X2A Poisoning by other opioids, intentional self-harm, initial encounter
T40.2X3A Poisoning by other opioids, assault, initial encounter
T40.2X4A Poisoning by other opioids, undetermined, initial encounter
T40.3X1A Poisoning by methadone, accidental (unintentional), initial encounter
T40.3X2A Poisoning by methadone, intentional self-harm, initial encounter
T40.3X3A Poisoning by methadone, assault, initial encounter
T40.3X4A Poisoning by methadone, undetermined, initial encounter
T40.491A Poisoning by other synthetic narcotics, accidental (unintentional), initial encounter
T40.492A Poisoning by other synthetic narcotics, intentional self-harm, initial encounter
T40.493A Poisoning by other synthetic narcotics, assault, initial encounter
T40.494A Poisoning by other synthetic narcotics, undetermined, initial encounter
T40.5X1A Poisoning by cocaine, accidental (unintentional), initial encounter
T40.5X2A Poisoning by cocaine, intentional self-harm, initial encounter
T40.5X3A Poisoning by cocaine, assault, initial encounter
T40.5X4A Poisoning by cocaine, undetermined, initial encounter
T40.601A Poisoning by unspecified narcotics, accidental (unintentional), initial encounter
T40.602A Poisoning by unspecified narcotics, intentional self-harm, initial encounter
T40.603A Poisoning by unspecified narcotics, assault, initial encounter
T40.604A Poisoning by unspecified narcotics, undetermined, initial encounter
T40.691A Poisoning by other narcotics, accidental (unintentional), initial encounter
T40.692A Poisoning by other narcotics, intentional self-harm, initial encounter
T40.693A Poisoning by other narcotics, assault, initial encounter
T40.694A Poisoning by other narcotics, undetermined, initial encounter
T40.711A Poisoning by cannabis, accidental (unintentional), initial encounter
T40.712A Poisoning by cannabis, intentional self-harm, initial encounter
T40.713A Poisoning by cannabis, assault, initial encounter
T40.714A Poisoning by cannabis, undetermined, initial encounter
T40.721A Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter
T40.722A Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter
T40.723A Poisoning by synthetic cannabinoids, assault, initial encounter
T40.724A Poisoning by synthetic cannabinoids, undetermined, initial encounter
T40.8X2A Poisoning by lysergide [LSD], intentional self-harm, initial encounter
T40.8X3A Poisoning by lysergide [LSD], assault, initial encounter
T40.8X4A Poisoning by lysergide [LSD], undetermined, initial encounter
T40.901A Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
T40.902A Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, initial encounter
T40.903A Poisoning by unspecified psychodysleptics [hallucinogens], assault, initial encounter
T40.904A Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, initial encounter
T40.991A Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
T40.992A Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter
T40.993A Poisoning by other psychodysleptics [hallucinogens], assault, initial encounter
T40.994A Poisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter
T42.0X1A Poisoning by hydantoin derivatives, accidental (unintentional), initial encounter
T42.0X2A Poisoning by hydantoin derivatives, intentional self-harm, initial encounter
T42.0X3A Poisoning by hydantoin derivatives, assault, initial encounter
T42.0X4A Poisoning by hydantoin derivatives, undetermined, initial encounter
T42.3X1A Poisoning by barbiturates, accidental (unintentional), initial encounter
T42.3X2A Poisoning by barbiturates, intentional self-harm, initial encounter
T42.3X3A Poisoning by barbiturates, assault, initial encounter
T42.3X4A Poisoning by barbiturates, undetermined, initial encounter
T42.4X1A Poisoning by benzodiazepines, accidental (unintentional), initial encounter
T42.4X2A Poisoning by benzodiazepines, intentional self-harm, initial encounter
T42.4X3A Poisoning by benzodiazepines, assault, initial encounter
T42.4X4A Poisoning by benzodiazepines, undetermined, initial encounter
T42.6X1A Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter
T42.6X2A Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter
T42.6X3A Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, initial encounter
T42.6X4A Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter
T43.011A Poisoning by tricyclic antidepressants, accidental (unintentional), initial encounter
T43.012A Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter
T43.013A Poisoning by tricyclic antidepressants, assault, initial encounter
T43.014A Poisoning by tricyclic antidepressants, undetermined, initial encounter
T43.021A Poisoning by tetracyclic antidepressants, accidental (unintentional), initial encounter
T43.022A Poisoning by tetracyclic antidepressants, intentional self-harm, initial encounter
T43.023A Poisoning by tetracyclic antidepressants, assault, initial encounter
T43.024A Poisoning by tetracyclic antidepressants, undetermined, initial encounter
T43.1X1A Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), initial encounter
T43.1X2A Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounter
T43.1X3A Poisoning by monoamine-oxidase-inhibitor antidepressants, assault, initial encounter
T43.1X4A Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, initial encounter
T43.201A Poisoning by unspecified antidepressants, accidental (unintentional), initial encounter
T43.202A Poisoning by unspecified antidepressants, intentional self-harm, initial encounter
T43.203A Poisoning by unspecified antidepressants, assault, initial encounter
T43.204A Poisoning by unspecified antidepressants, undetermined, initial encounter
T43.211A Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), initial encounter
T43.212A Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter
T43.213A Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, initial encounter
T43.214A Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, initial encounter
T43.221A Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), initial encounter
T43.222A Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter
T43.223A Poisoning by selective serotonin reuptake inhibitors, assault, initial encounter
T43.224A Poisoning by selective serotonin reuptake inhibitors, undetermined, initial encounter
T43.291A Poisoning by other antidepressants, accidental (unintentional), initial encounter
T43.292A Poisoning by other antidepressants, intentional self-harm, initial encounter
T43.293A Poisoning by other antidepressants, assault, initial encounter
T43.294A Poisoning by other antidepressants, undetermined, initial encounter
T43.3X1A Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T43.3X2A Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, initial encounter
T43.3X3A Poisoning by phenothiazine antipsychotics and neuroleptics, assault, initial encounter
T43.3X4A Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, initial encounter
T43.4X1A Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), initial encounter
T43.4X2A Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, initial encounter
T43.4X3A Poisoning by butyrophenone and thiothixene neuroleptics, assault, initial encounter
T43.4X4A Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, initial encounter
T43.501A Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T43.502A Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, initial encounter
T43.503A Poisoning by unspecified antipsychotics and neuroleptics, assault, initial encounter
T43.504A Poisoning by unspecified antipsychotics and neuroleptics, undetermined, initial encounter
T43.591A Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T43.592A Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter
T43.593A Poisoning by other antipsychotics and neuroleptics, assault, initial encounter
T43.594A Poisoning by other antipsychotics and neuroleptics, undetermined, initial encounter
T43.601A Poisoning by unspecified psychostimulants, accidental (unintentional), initial encounter
T43.602A Poisoning by unspecified psychostimulants, intentional self-harm, initial encounter
T43.603A Poisoning by unspecified psychostimulants, assault, initial encounter
T43.604A Poisoning by unspecified psychostimulants, undetermined, initial encounter
T43.611A Poisoning by caffeine, accidental (unintentional), initial encounter
T43.612A Poisoning by caffeine, intentional self-harm, initial encounter
T43.613A Poisoning by caffeine, assault, initial encounter
T43.614A Poisoning by caffeine, undetermined, initial encounter
T43.621A Poisoning by amphetamines, accidental (unintentional), initial encounter
T43.622A Poisoning by amphetamines, intentional self-harm, initial encounter
T43.623A Poisoning by amphetamines, assault, initial encounter
T43.624A Poisoning by amphetamines, undetermined, initial encounter
T43.631A Poisoning by methylphenidate, accidental (unintentional), initial encounter
T43.632A Poisoning by methylphenidate, intentional self-harm, initial encounter
T43.633A Poisoning by methylphenidate, assault, initial encounter
T43.634A Poisoning by methylphenidate, undetermined, initial encounter
T43.641A Poisoning by ecstasy, accidental (unintentional), initial encounter
T43.642A Poisoning by ecstasy, intentional self-harm, initial encounter
T43.643A Poisoning by ecstasy, assault, initial encounter
T43.644A Poisoning by ecstasy, undetermined, initial encounter
T43.691A Poisoning by other psychostimulants, accidental (unintentional), initial encounter
T43.692A Poisoning by other psychostimulants, intentional self-harm, initial encounter
T43.693A Poisoning by other psychostimulants, assault, initial encounter
T43.694A Poisoning by other psychostimulants, undetermined, initial encounter
T43.8X1A Poisoning by other psychotropic drugs, accidental (unintentional), initial encounter
T43.8X2A Poisoning by other psychotropic drugs, intentional self-harm, initial encounter
T43.8X3A Poisoning by other psychotropic drugs, assault, initial encounter
T43.8X4A Poisoning by other psychotropic drugs, undetermined, initial encounter
T43.91XA Poisoning by unspecified psychotropic drug, accidental (unintentional), initial encounter
T43.92XA Poisoning by unspecified psychotropic drug, intentional self-harm, initial encounter
T43.93XA Poisoning by unspecified psychotropic drug, assault, initial encounter
T43.94XA Poisoning by unspecified psychotropic drug, undetermined, initial encounter
T45.0X1A Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
T45.0X2A Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
T45.0X3A Poisoning by antiallergic and antiemetic drugs, assault, initial encounter
T45.0X4A Poisoning by antiallergic and antiemetic drugs, undetermined, initial encounter
T46.0X1A Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
T46.0X2A Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
T46.0X3A Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
T46.0X4A Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
T50.901A Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
T50.902A Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
T50.903A Poisoning by unspecified drugs, medicaments and biological substances, assault, initial encounter
T50.904A Poisoning by unspecified drugs, medicaments and biological substances, undetermined, initial encounter
T50.911A Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
T50.912A Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
T50.913A Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, initial encounter
T50.914A Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, initial encounter
T50.991A Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), initial encounter
Z71.51 Drug abuse counseling and surveillance of drug abuser
Z79.891 Long term (current) use of opiate analgesic
Z79.899 Other long term (current) drug therapy
Z91.120 Patient's intentional underdosing of medication regimen due to financial hardship
Z91.128 Patient's intentional underdosing of medication regimen for other reason
Z91.130 Patient's unintentional underdosing of medication regimen due to age-related debility
Z91.138 Patient's unintentional underdosing of medication regimen for other reason
Z91.14 Patient's other noncompliance with medication regimen
Z91.19 Patient's noncompliance with other medical treatment and regimen

It is the provider’s responsibility to select codes carried out to the highest level of specificity and selected from the ICD-10-CM code book appropriate to the year in which the service is rendered for the claim(s) submitted.

Physicians are to select the most appropriate diagnosis code. Labs are not to prepopulate requisition forms with diagnosis codes.

The following ICD-10-CM codes support medical necessity and provide coverage for HCPCS codes: G0480, G0481, G0482, G0483, or G0659 (Definitive UDT)

E03.5 Myxedema coma
E87.2 Acidosis
F10.11 Alcohol abuse, in remission
F10.120 Alcohol abuse with intoxication, uncomplicated
F10.121 Alcohol abuse with intoxication delirium
F10.129 Alcohol abuse with intoxication, unspecified
F10.130 Alcohol abuse with withdrawal, uncomplicated
F10.131 Alcohol abuse with withdrawal delirium
F10.132 Alcohol abuse with withdrawal with perceptual disturbance
F10.14 Alcohol abuse with alcohol-induced mood disorder
F10.150 Alcohol abuse with alcohol-induced psychotic disorder with delusions
F10.151 Alcohol abuse with alcohol-induced psychotic disorder with hallucinations
F10.159 Alcohol abuse with alcohol-induced psychotic disorder, unspecified
F10.180 Alcohol abuse with alcohol-induced anxiety disorder
F10.181 Alcohol abuse with alcohol-induced sexual dysfunction
F10.182 Alcohol abuse with alcohol-induced sleep disorder
F10.188 Alcohol abuse with other alcohol-induced disorder
F10.19 Alcohol abuse with unspecified alcohol-induced disorder
F10.20 Alcohol dependence, uncomplicated
F10.21 Alcohol dependence, in remission
F10.220 Alcohol dependence with intoxication, uncomplicated
F10.221 Alcohol dependence with intoxication delirium
F10.229 Alcohol dependence with intoxication, unspecified
F10.230 Alcohol dependence with withdrawal, uncomplicated
F10.231 Alcohol dependence with withdrawal delirium
F10.232 Alcohol dependence with withdrawal with perceptual disturbance
F10.239 Alcohol dependence with withdrawal, unspecified
F10.24 Alcohol dependence with alcohol-induced mood disorder
F10.250 Alcohol dependence with alcohol-induced psychotic disorder with delusions
F10.251 Alcohol dependence with alcohol-induced psychotic disorder with hallucinations
F10.259 Alcohol dependence with alcohol-induced psychotic disorder, unspecified
F10.26 Alcohol dependence with alcohol-induced persisting amnestic disorder
F10.27 Alcohol dependence with alcohol-induced persisting dementia
F10.280 Alcohol dependence with alcohol-induced anxiety disorder
F10.281 Alcohol dependence with alcohol-induced sexual dysfunction
F10.282 Alcohol dependence with alcohol-induced sleep disorder
F10.288 Alcohol dependence with other alcohol-induced disorder
F10.29 Alcohol dependence with unspecified alcohol-induced disorder
F10.920 Alcohol use, unspecified with intoxication, uncomplicated
F10.921 Alcohol use, unspecified with intoxication delirium
F10.929 Alcohol use, unspecified with intoxication, unspecified
F10.94 Alcohol use, unspecified with alcohol-induced mood disorder
F10.950 Alcohol use, unspecified with alcohol-induced psychotic disorder with delusions
F10.951 Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations
F10.959 Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified
F10.96 Alcohol use, unspecified with alcohol-induced persisting amnestic disorder
F10.97 Alcohol use, unspecified with alcohol-induced persisting dementia
F10.980 Alcohol use, unspecified with alcohol-induced anxiety disorder
F10.981 Alcohol use, unspecified with alcohol-induced sexual dysfunction
F10.982 Alcohol use, unspecified with alcohol-induced sleep disorder
F10.988 Alcohol use, unspecified with other alcohol-induced disorder
F10.99 Alcohol use, unspecified with unspecified alcohol-induced disorder
F11.11 Opioid abuse, in remission
F11.120 Opioid abuse with intoxication, uncomplicated
F11.121 Opioid abuse with intoxication delirium
F11.122 Opioid abuse with intoxication with perceptual disturbance
F11.129 Opioid abuse with intoxication, unspecified
F11.13 Opioid abuse with withdrawal
F11.14 Opioid abuse with opioid-induced mood disorder
F11.150 Opioid abuse with opioid-induced psychotic disorder with delusions
F11.151 Opioid abuse with opioid-induced psychotic disorder with hallucinations
F11.159 Opioid abuse with opioid-induced psychotic disorder, unspecified
F11.181 Opioid abuse with opioid-induced sexual dysfunction
F11.182 Opioid abuse with opioid-induced sleep disorder
F11.188 Opioid abuse with other opioid-induced disorder
F11.19 Opioid abuse with unspecified opioid-induced disorder
F11.20 Opioid dependence, uncomplicated
F11.21 Opioid dependence, in remission
F11.220 Opioid dependence with intoxication, uncomplicated
F11.221 Opioid dependence with intoxication delirium
F11.222 Opioid dependence with intoxication with perceptual disturbance
F11.229 Opioid dependence with intoxication, unspecified
F11.23 Opioid dependence with withdrawal
F11.24 Opioid dependence with opioid-induced mood disorder
F11.250 Opioid dependence with opioid-induced psychotic disorder with delusions
F11.251 Opioid dependence with opioid-induced psychotic disorder with hallucinations
F11.281 Opioid dependence with opioid-induced sexual dysfunction
F11.282 Opioid dependence with opioid-induced sleep disorder
F11.288 Opioid dependence with other opioid-induced disorder
F11.29 Opioid dependence with unspecified opioid-induced disorder
F11.90 Opioid use, unspecified, uncomplicated
F11.920 Opioid use, unspecified with intoxication, uncomplicated
F11.921 Opioid use, unspecified with intoxication delirium
F11.922 Opioid use, unspecified with intoxication with perceptual disturbance
F11.929 Opioid use, unspecified with intoxication, unspecified
F11.93 Opioid use, unspecified with withdrawal
F11.94 Opioid use, unspecified with opioid-induced mood disorder
F11.950 Opioid use, unspecified with opioid-induced psychotic disorder with delusions
F11.951 Opioid use, unspecified with opioid-induced psychotic disorder with hallucinations
F11.959 Opioid use, unspecified with opioid-induced psychotic disorder, unspecified
F11.981 Opioid use, unspecified with opioid-induced sexual dysfunction
F11.982 Opioid use, unspecified with opioid-induced sleep disorder
F11.988 Opioid use, unspecified with other opioid-induced disorder
F11.99 Opioid use, unspecified with unspecified opioid-induced disorder
F12.11 Cannabis abuse, in remission
F12.120 Cannabis abuse with intoxication, uncomplicated
F12.121 Cannabis abuse with intoxication delirium
F12.122 Cannabis abuse with intoxication with perceptual disturbance
F12.129 Cannabis abuse with intoxication, unspecified
F12.13 Cannabis abuse with withdrawal
F12.150 Cannabis abuse with psychotic disorder with delusions
F12.151 Cannabis abuse with psychotic disorder with hallucinations
F12.159 Cannabis abuse with psychotic disorder, unspecified
F12.180 Cannabis abuse with cannabis-induced anxiety disorder
F12.188 Cannabis abuse with other cannabis-induced disorder
F12.19 Cannabis abuse with unspecified cannabis-induced disorder
F12.20 Cannabis dependence, uncomplicated
F12.21 Cannabis dependence, in remission
F12.220 Cannabis dependence with intoxication, uncomplicated
F12.221 Cannabis dependence with intoxication delirium
F12.222 Cannabis dependence with intoxication with perceptual disturbance
F12.229 Cannabis dependence with intoxication, unspecified
F12.23 Cannabis dependence with withdrawal
F12.250 Cannabis dependence with psychotic disorder with delusions
F12.251 Cannabis dependence with psychotic disorder with hallucinations
F12.259 Cannabis dependence with psychotic disorder, unspecified
F12.280 Cannabis dependence with cannabis-induced anxiety disorder
F12.288 Cannabis dependence with other cannabis-induced disorder
F12.29 Cannabis dependence with unspecified cannabis-induced disorder
F12.90 Cannabis use, unspecified, uncomplicated
F12.920 Cannabis use, unspecified with intoxication, uncomplicated
F12.921 Cannabis use, unspecified with intoxication delirium
F12.922 Cannabis use, unspecified with intoxication with perceptual disturbance
F12.929 Cannabis use, unspecified with intoxication, unspecified
F12.93 Cannabis use, unspecified with withdrawal
F12.950 Cannabis use, unspecified with psychotic disorder with delusions
F12.951 Cannabis use, unspecified with psychotic disorder with hallucinations
F12.959 Cannabis use, unspecified with psychotic disorder, unspecified
F12.980 Cannabis use, unspecified with anxiety disorder
F12.988 Cannabis use, unspecified with other cannabis-induced disorder
F12.99 Cannabis use, unspecified with unspecified cannabis-induced disorder
F13.10 Sedative, hypnotic or anxiolytic abuse, uncomplicated
F13.11 Sedative, hypnotic or anxiolytic abuse, in remission
F13.120 Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated
F13.121 Sedative, hypnotic or anxiolytic abuse with intoxication delirium
F13.129 Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified
F13.130 Sedative, hypnotic or anxiolytic abuse with withdrawal, uncomplicated
F13.131 Sedative, hypnotic or anxiolytic abuse with withdrawal delirium
F13.132 Sedative, hypnotic or anxiolytic abuse with withdrawal with perceptual disturbance
F13.14 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder
F13.150 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions
F13.151 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations
F13.159 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
F13.180 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder
F13.181 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction
F13.182 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder
F13.188 Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder
F13.19 Sedative, hypnotic or anxiolytic abuse with unspecified sedative, hypnotic or anxiolytic-induced disorder
F13.20 Sedative, hypnotic or anxiolytic dependence, uncomplicated
F13.21 Sedative, hypnotic or anxiolytic dependence, in remission
F13.220 Sedative, hypnotic or anxiolytic dependence with intoxication, uncomplicated
F13.221 Sedative, hypnotic or anxiolytic dependence with intoxication delirium
F13.229 Sedative, hypnotic or anxiolytic dependence with intoxication, unspecified
F13.230 Sedative, hypnotic or anxiolytic dependence with withdrawal, uncomplicated
F13.231 Sedative, hypnotic or anxiolytic dependence with withdrawal delirium
F13.232 Sedative, hypnotic or anxiolytic dependence with withdrawal with perceptual disturbance
F13.239 Sedative, hypnotic or anxiolytic dependence with withdrawal, unspecified
F13.24 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder
F13.250 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions
F13.251 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations
F13.259 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
F13.26 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder
F13.27 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia
F13.280 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder
F13.281 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction
F13.282 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder
F13.288 Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder
F13.29 Sedative, hypnotic or anxiolytic dependence with unspecified sedative, hypnotic or anxiolytic-induced disorder
F13.90 Sedative, hypnotic, or anxiolytic use, unspecified, uncomplicated
F13.920 Sedative, hypnotic or anxiolytic use, unspecified with intoxication, uncomplicated
F13.921 Sedative, hypnotic or anxiolytic use, unspecified with intoxication delirium
F13.929 Sedative, hypnotic or anxiolytic use, unspecified with intoxication, unspecified
F13.930 Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated
F13.931 Sedative, hypnotic or anxiolytic use, unspecified with withdrawal delirium
F13.932 Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances
F13.939 Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified
F13.94 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder
F13.950 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions
F13.951 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations
F13.959 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
F13.96 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder
F13.97 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting dementia
F13.980 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder
F13.981 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction
F13.982 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder
F13.988 Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorder
F13.99 Sedative, hypnotic or anxiolytic use, unspecified with unspecified sedative, hypnotic or anxiolytic-induced disorder
F14.10 Cocaine abuse, uncomplicated
F14.11 Cocaine abuse, in remission
F14.120 Cocaine abuse with intoxication, uncomplicated
F14.121 Cocaine abuse with intoxication with delirium
F14.122 Cocaine abuse with intoxication with perceptual disturbance
F14.13 Cocaine abuse, unspecified with withdrawal
F14.14 Cocaine abuse with cocaine-induced mood disorder
F14.150 Cocaine abuse with cocaine-induced psychotic disorder with delusions
F14.151 Cocaine abuse with cocaine-induced psychotic disorder with hallucinations
F14.159 Cocaine abuse with cocaine-induced psychotic disorder, unspecified
F14.180 Cocaine abuse with cocaine-induced anxiety disorder
F14.181 Cocaine abuse with cocaine-induced sexual dysfunction
F14.182 Cocaine abuse with cocaine-induced sleep disorder
F14.188 Cocaine abuse with other cocaine-induced disorder
F14.19 Cocaine abuse with unspecified cocaine-induced disorder
F14.20 Cocaine dependence, uncomplicated
F14.220 Cocaine dependence with intoxication, uncomplicated
F14.221 Cocaine dependence with intoxication delirium
F14.222 Cocaine dependence with intoxication with perceptual disturbance
F14.229 Cocaine dependence with intoxication, unspecified
F14.250 Cocaine dependence with cocaine-induced psychotic disorder with delusions
F14.251 Cocaine dependence with cocaine-induced psychotic disorder with hallucinations
F14.259 Cocaine dependence with cocaine-induced psychotic disorder, unspecified
F14.280 Cocaine dependence with cocaine-induced anxiety disorder
F14.281 Cocaine dependence with cocaine-induced sexual dysfunction
F14.282 Cocaine dependence with cocaine-induced sleep disorder
F14.288 Cocaine dependence with other cocaine-induced disorder
F14.29 Cocaine dependence with unspecified cocaine-induced disorder
F14.90 Cocaine use, unspecified, uncomplicated
F14.920 Cocaine use, unspecified with intoxication, uncomplicated
F14.921 Cocaine use, unspecified with intoxication delirium
F14.922 Cocaine use, unspecified with intoxication with perceptual disturbance
F14.929 Cocaine use, unspecified with intoxication, unspecified
F14.93 Cocaine use, unspecified with withdrawal
F14.94 Cocaine use, unspecified with cocaine-induced mood disorder
F14.950 Cocaine use, unspecified with cocaine-induced psychotic disorder with delusions
F14.951 Cocaine use, unspecified with cocaine-induced psychotic disorder with hallucinations
F14.959 Cocaine use, unspecified with cocaine-induced psychotic disorder, unspecified
F14.980 Cocaine use, unspecified with cocaine-induced anxiety disorder
F14.981 Cocaine use, unspecified with cocaine-induced sexual dysfunction
F14.982 Cocaine use, unspecified with cocaine-induced sleep disorder
F14.988 Cocaine use, unspecified with other cocaine-induced disorder
F14.99 Cocaine use, unspecified with unspecified cocaine-induced disorder
F15.10 Other stimulant abuse, uncomplicated
F15.11 Other stimulant abuse, in remission
F15.120 Other stimulant abuse with intoxication, uncomplicated
F15.121 Other stimulant abuse with intoxication delirium
F15.122 Other stimulant abuse with intoxication with perceptual disturbance
F15.129 Other stimulant abuse with intoxication, unspecified
F15.13 Other stimulant abuse with withdrawal
F15.14 Other stimulant abuse with stimulant-induced mood disorder
F15.150 Other stimulant abuse with stimulant-induced psychotic disorder with delusions
F15.151 Other stimulant abuse with stimulant-induced psychotic disorder with hallucinations
F15.159 Other stimulant abuse with stimulant-induced psychotic disorder, unspecified
F15.180 Other stimulant abuse with stimulant-induced anxiety disorder
F15.181 Other stimulant abuse with stimulant-induced sexual dysfunction
F15.182 Other stimulant abuse with stimulant-induced sleep disorder
F15.188 Other stimulant abuse with other stimulant-induced disorder
F15.19 Other stimulant abuse with unspecified stimulant-induced disorder
F15.20 Other stimulant dependence, uncomplicated
F15.21 Other stimulant dependence, in remission
F15.220 Other stimulant dependence with intoxication, uncomplicated
F15.221 Other stimulant dependence with intoxication delirium
F15.222 Other stimulant dependence with intoxication with perceptual disturbance
F15.229 Other stimulant dependence with intoxication, unspecified
F15.23 Other stimulant dependence with withdrawal
F15.24 Other stimulant dependence with stimulant-induced mood disorder
F15.250 Other stimulant dependence with stimulant-induced psychotic disorder with delusions
F15.251 Other stimulant dependence with stimulant-induced psychotic disorder with hallucinations
F15.259 Other stimulant dependence with stimulant-induced psychotic disorder, unspecified
F15.280 Other stimulant dependence with stimulant-induced anxiety disorder
F15.281 Other stimulant dependence with stimulant-induced sexual dysfunction
F15.282 Other stimulant dependence with stimulant-induced sleep disorder
F15.288 Other stimulant dependence with other stimulant-induced disorder
F15.29 Other stimulant dependence with unspecified stimulant-induced disorder
F15.90 Other stimulant use, unspecified, uncomplicated
F15.920 Other stimulant use, unspecified with intoxication, uncomplicated
F15.921 Other stimulant use, unspecified with intoxication delirium
F15.922 Other stimulant use, unspecified with intoxication with perceptual disturbance
F15.929 Other stimulant use, unspecified with intoxication, unspecified
F15.93 Other stimulant use, unspecified with withdrawal
F15.94 Other stimulant use, unspecified with stimulant-induced mood disorder
F15.950 Other stimulant use, unspecified with stimulant-induced psychotic disorder with delusions
F15.951 Other stimulant use, unspecified with stimulant-induced psychotic disorder with hallucinations
F15.959 Other stimulant use, unspecified with stimulant-induced psychotic disorder, unspecified
F15.980 Other stimulant use, unspecified with stimulant-induced anxiety disorder
F15.981 Other stimulant use, unspecified with stimulant-induced sexual dysfunction
F15.982 Other stimulant use, unspecified with stimulant-induced sleep disorder
F15.988 Other stimulant use, unspecified with other stimulant-induced disorder
F15.99 Other stimulant use, unspecified with unspecified stimulant-induced disorder
F16.10 Hallucinogen abuse, uncomplicated
F16.11 Hallucinogen abuse, in remission
F16.120 Hallucinogen abuse with intoxication, uncomplicated
F16.121 Hallucinogen abuse with intoxication with delirium
F16.122 Hallucinogen abuse with intoxication with perceptual disturbance
F16.129 Hallucinogen abuse with intoxication, unspecified
F16.150 Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions
F16.151 Hallucinogen abuse with hallucinogen-induced psychotic disorder with hallucinations
F16.159 Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified
F16.180 Hallucinogen abuse with hallucinogen-induced anxiety disorder
F16.183 Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks)
F16.188 Hallucinogen abuse with other hallucinogen-induced disorder
F16.19 Hallucinogen abuse with unspecified hallucinogen-induced disorder
F16.20 Hallucinogen dependence, uncomplicated
F16.21 Hallucinogen dependence, in remission
F16.220 Hallucinogen dependence with intoxication, uncomplicated
F16.221 Hallucinogen dependence with intoxication with delirium
F16.229 Hallucinogen dependence with intoxication, unspecified
F16.24 Hallucinogen dependence with hallucinogen-induced mood disorder
F16.250 Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions
F16.251 Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations
F16.259 Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified
F16.280 Hallucinogen dependence with hallucinogen-induced anxiety disorder
F16.283 Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks)
F16.288 Hallucinogen dependence with other hallucinogen-induced disorder
F16.29 Hallucinogen dependence with unspecified hallucinogen-induced disorder
F16.90 Hallucinogen use, unspecified, uncomplicated
F16.920 Hallucinogen use, unspecified with intoxication, uncomplicated
F16.921 Hallucinogen use, unspecified with intoxication with delirium
F16.929 Hallucinogen use, unspecified with intoxication, unspecified
F16.94 Hallucinogen use, unspecified with hallucinogen-induced mood disorder
F16.950 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with delusions
F16.951 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations
F16.959 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified
F16.980 Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder
F16.983 Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks)
F16.988 Hallucinogen use, unspecified with other hallucinogen-induced disorder
F16.99 Hallucinogen use, unspecified with unspecified hallucinogen-induced disorder
F18.10 Inhalant abuse, uncomplicated
F18.11 Inhalant abuse, in remission
F18.120 Inhalant abuse with intoxication, uncomplicated
F18.121 Inhalant abuse with intoxication delirium
F18.129 Inhalant abuse with intoxication, unspecified
F18.14 Inhalant abuse with inhalant-induced mood disorder
F18.150 Inhalant abuse with inhalant-induced psychotic disorder with delusions
F18.151 Inhalant abuse with inhalant-induced psychotic disorder with hallucinations
F18.159 Inhalant abuse with inhalant-induced psychotic disorder, unspecified
F18.17 Inhalant abuse with inhalant-induced dementia
F18.180 Inhalant abuse with inhalant-induced anxiety disorder
F18.188 Inhalant abuse with other inhalant-induced disorder
F18.19 Inhalant abuse with unspecified inhalant-induced disorder
F18.20 Inhalant dependence, uncomplicated
F18.21 Inhalant dependence, in remission
F18.220 Inhalant dependence with intoxication, uncomplicated
F18.221 Inhalant dependence with intoxication delirium
F18.229 Inhalant dependence with intoxication, unspecified
F18.24 Inhalant dependence with inhalant-induced mood disorder
F18.250 Inhalant dependence with inhalant-induced psychotic disorder with delusions
F18.251 Inhalant dependence with inhalant-induced psychotic disorder with hallucinations
F18.259 Inhalant dependence with inhalant-induced psychotic disorder, unspecified
F18.27 Inhalant dependence with inhalant-induced dementia
F18.280 Inhalant dependence with inhalant-induced anxiety disorder
F18.288 Inhalant dependence with other inhalant-induced disorder
F18.29 Inhalant dependence with unspecified inhalant-induced disorder
F18.90 Inhalant use, unspecified, uncomplicated
F18.920 Inhalant use, unspecified with intoxication, uncomplicated
F18.921 Inhalant use, unspecified with intoxication with delirium
F18.929 Inhalant use, unspecified with intoxication, unspecified
F18.94 Inhalant use, unspecified with inhalant-induced mood disorder
F18.950 Inhalant use, unspecified with inhalant-induced psychotic disorder with delusions
F18.951 Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations
F18.959 Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified
F18.980 Inhalant use, unspecified with inhalant-induced anxiety disorder
F18.988 Inhalant use, unspecified with other inhalant-induced disorder
F18.99 Inhalant use, unspecified with unspecified inhalant-induced disorder
F19.10 Other psychoactive substance abuse, uncomplicated
F19.11 Other psychoactive substance abuse, in remission
F19.120 Other psychoactive substance abuse with intoxication, uncomplicated
F19.121 Other psychoactive substance abuse with intoxication delirium
F19.122 Other psychoactive substance abuse with intoxication with perceptual disturbances
F19.129 Other psychoactive substance abuse with intoxication, unspecified
F19.130 Other psychoactive substance abuse with withdrawal, uncomplicated
F19.131 Other psychoactive substance abuse with withdrawal delirium
F19.132 Other psychoactive substance abuse with withdrawal with perceptual disturbance
F19.14 Other psychoactive substance abuse with psychoactive substance-induced mood disorder
F19.150 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with delusions
F19.151 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations
F19.159 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified
F19.16 Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder
F19.17 Other psychoactive substance abuse with psychoactive substance-induced persisting dementia
F19.180 Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder
F19.181 Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction
F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
F19.188 Other psychoactive substance abuse with other psychoactive substance-induced disorder
F19.19 Other psychoactive substance abuse with unspecified psychoactive substance-induced disorder
F19.20 Other psychoactive substance dependence, uncomplicated
F19.21 Other psychoactive substance dependence, in remission
F19.220 Other psychoactive substance dependence with intoxication, uncomplicated
F19.221 Other psychoactive substance dependence with intoxication delirium
F19.222 Other psychoactive substance dependence with intoxication with perceptual disturbance
F19.229 Other psychoactive substance dependence with intoxication, unspecified
F19.230 Other psychoactive substance dependence with withdrawal, uncomplicated
F19.231 Other psychoactive substance dependence with withdrawal delirium
F19.232 Other psychoactive substance dependence with withdrawal with perceptual disturbance
F19.239 Other psychoactive substance dependence with withdrawal, unspecified
F19.24 Other psychoactive substance dependence with psychoactive substance-induced mood disorder
F19.250 Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with delusions
F19.251 Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with hallucinations
F19.259 Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified
F19.26 Other psychoactive substance dependence with psychoactive substance-induced persisting amnestic disorder
F19.27 Other psychoactive substance dependence with psychoactive substance-induced persisting dementia
F19.280 Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder
F19.281 Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction
F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
F19.288 Other psychoactive substance dependence with other psychoactive substance-induced disorder
F19.29 Other psychoactive substance dependence with unspecified psychoactive substance-induced disorder
F19.90 Other psychoactive substance use, unspecified, uncomplicated
F19.920 Other psychoactive substance use, unspecified with intoxication, uncomplicated
F19.921 Other psychoactive substance use, unspecified with intoxication with delirium
F19.922 Other psychoactive substance use, unspecified with intoxication with perceptual disturbance
F19.929 Other psychoactive substance use, unspecified with intoxication, unspecified
F19.930 Other psychoactive substance use, unspecified with withdrawal, uncomplicated
F19.931 Other psychoactive substance use, unspecified with withdrawal delirium
F19.932 Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance
F19.939 Other psychoactive substance use, unspecified with withdrawal, unspecified
F19.94 Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder
F19.950 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions
F19.951 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations
F19.959 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified
F19.96 Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder
F19.97 Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia
F19.980 Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder
F19.981 Other psychoactive substance use, unspecified with psychoactive substance-induced sexual dysfunction
F19.982 Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder
F19.988 Other psychoactive substance use, unspecified with other psychoactive substance-induced disorder
F19.99 Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder
F20.0 Paranoid schizophrenia
F20.1 Disorganized schizophrenia
F20.2 Catatonic schizophrenia
F20.3 Undifferentiated schizophrenia
F20.5 Residual schizophrenia
F20.81 Schizophreniform disorder
F20.89 Other schizophrenia
F20.9 Schizophrenia, unspecified
F23 Brief psychotic disorder
F25.0 Schizoaffective disorder, bipolar type
F25.1 Schizoaffective disorder, depressive type
F25.8 Other schizoaffective disorders
F25.9 Schizoaffective disorder, unspecified
F28 Other psychotic disorder not due to a substance or known physiological condition
F29 Unspecified psychosis not due to a substance or known physiological condition
F30.10 Manic episode without psychotic symptoms, unspecified
F30.11 Manic episode without psychotic symptoms, mild
F30.12 Manic episode without psychotic symptoms, moderate
F30.13 Manic episode, severe, without psychotic symptoms
F30.2 Manic episode, severe with psychotic symptoms
F30.3 Manic episode in partial remission
F30.4 Manic episode in full remission
F30.8 Other manic episodes
F30.9 Manic episode, unspecified
F31.10 Bipolar disorder, current episode manic without psychotic features, unspecified
F31.11 Bipolar disorder, current episode manic without psychotic features, mild
F31.12 Bipolar disorder, current episode manic without psychotic features, moderate
F31.13 Bipolar disorder, current episode manic without psychotic features, severe
F31.2 Bipolar disorder, current episode manic severe with psychotic features
F31.30 Bipolar disorder, current episode depressed, mild or moderate severity, unspecified
F31.31 Bipolar disorder, current episode depressed, mild
F31.32 Bipolar disorder, current episode depressed, moderate
F31.4 Bipolar disorder, current episode depressed, severe, without psychotic features
F31.5 Bipolar disorder, current episode depressed, severe, with psychotic features
F31.60 Bipolar disorder, current episode mixed, unspecified
F31.61 Bipolar disorder, current episode mixed, mild
F31.62 Bipolar disorder, current episode mixed, moderate
F31.63 Bipolar disorder, current episode mixed, severe, without psychotic features
F31.64 Bipolar disorder, current episode mixed, severe, with psychotic features
F31.70 Bipolar disorder, currently in remission, most recent episode unspecified
F31.71 Bipolar disorder, in partial remission, most recent episode hypomanic
F31.72 Bipolar disorder, in full remission, most recent episode hypomanic
F31.73 Bipolar disorder, in partial remission, most recent episode manic
F31.74 Bipolar disorder, in full remission, most recent episode manic
F31.75 Bipolar disorder, in partial remission, most recent episode depressed
F31.76 Bipolar disorder, in full remission, most recent episode depressed
F31.77 Bipolar disorder, in partial remission, most recent episode mixed
F31.78 Bipolar disorder, in full remission, most recent episode mixed
F31.81 Bipolar II disorder
F31.89 Other bipolar disorder
F31.9 Bipolar disorder, unspecified
F32.0 Major depressive disorder, single episode, mild
F32.1 Major depressive disorder, single episode, moderate
F32.2 Major depressive disorder, single episode, severe without psychotic features
F32.3 Major depressive disorder, single episode, severe with psychotic features
F32.4 Major depressive disorder, single episode, in partial remission
F32.5 Major depressive disorder, single episode, in full remission
F32.81 Premenstrual dysphoric disorder
F32.89 Other specified depressive episodes
F32.9 Major depressive disorder, single episode, unspecified
F33.0 Major depressive disorder, recurrent, mild
F33.1 Major depressive disorder, recurrent, moderate
F33.2 Major depressive disorder, recurrent severe without psychotic features
F33.3 Major depressive disorder, recurrent, severe with psychotic symptoms
F33.40 Major depressive disorder, recurrent, in remission, unspecified
F33.41 Major depressive disorder, recurrent, in partial remission
F33.42 Major depressive disorder, recurrent, in full remission
F33.8 Other recurrent depressive disorders
F33.9 Major depressive disorder, recurrent, unspecified
F34.0 Cyclothymic disorder
F34.1 Dysthymic disorder
F34.81 Disruptive mood dysregulation disorder
F34.89 Other specified persistent mood disorders
F34.9 Persistent mood [affective] disorder, unspecified
F39 Unspecified mood [affective] disorder
F43.0 Acute stress reaction
F43.10 Post-traumatic stress disorder, unspecified
F43.11 Post-traumatic stress disorder, acute
F43.12 Post-traumatic stress disorder, chronic
F43.20 Adjustment disorder, unspecified
F43.21 Adjustment disorder with depressed mood
F43.22 Adjustment disorder with anxiety
F43.23 Adjustment disorder with mixed anxiety and depressed mood
F43.24 Adjustment disorder with disturbance of conduct
F43.25 Adjustment disorder with mixed disturbance of emotions and conduct
F43.29 Adjustment disorder with other symptoms
F43.8 Other reactions to severe stress
F43.9 Reaction to severe stress, unspecified
F44.0 Dissociative amnesia
F44.1 Dissociative fugue
F44.2 Dissociative stupor
F44.4 Conversion disorder with motor symptom or deficit
F44.5 Conversion disorder with seizures or convulsions
F44.6 Conversion disorder with sensory symptom or deficit
F44.7 Conversion disorder with mixed symptom presentation
F44.81 Dissociative identity disorder
F44.89 Other dissociative and conversion disorders
F44.9 Dissociative and conversion disorder, unspecified
F45.0 Somatization disorder
F45.1 Undifferentiated somatoform disorder
F45.20 Hypochondriacal disorder, unspecified
F45.21 Hypochondriasis
F45.22 Body dysmorphic disorder
F45.29 Other hypochondriacal disorders
F45.41 Pain disorder exclusively related to psychological factors
F45.42 Pain disorder with related psychological factors
F45.8 Other somatoform disorders
F45.9 Somatoform disorder, unspecified
F55.0 Abuse of antacids
F55.1 Abuse of herbal or folk remedies
F55.2 Abuse of laxatives
F55.3 Abuse of steroids or hormones
F55.4 Abuse of vitamins
F55.8 Abuse of other non-psychoactive substances
F60.0 Paranoid personality disorder
F60.1 Schizoid personality disorder
F60.2 Antisocial personality disorder
F60.3 Borderline personality disorder
F60.4 Histrionic personality disorder
F60.5 Obsessive-compulsive personality disorder
F60.6 Avoidant personality disorder
F60.7 Dependent personality disorder
F60.81 Narcissistic personality disorder
F60.89 Other specific personality disorders
F60.9 Personality disorder, unspecified
G40.001 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status epilepticus
G40.009 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus
G40.011 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, with status epilepticus
G40.019 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus
G40.101 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus
G40.109 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus
G40.111 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus
G40.119 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus
G40.201 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus
G40.209 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus
G40.211 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus
G40.219 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus
G40.301 Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus
G40.309 Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus
G40.311 Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus
G40.319 Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus
G40.401 Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus
G40.409 Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus
G40.411 Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus
G40.419 Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus
G40.501 Epileptic seizures related to external causes, not intractable, with status epilepticus
G40.509 Epileptic seizures related to external causes, not intractable, without status epilepticus
G40.801 Other epilepsy, not intractable, with status epilepticus
G40.802 Other epilepsy, not intractable, without status epilepticus
G40.803 Other epilepsy, intractable, with status epilepticus
G40.804 Other epilepsy, intractable, without status epilepticus
G40.811 Lennox-Gastaut syndrome, not intractable, with status epilepticus
G40.812 Lennox-Gastaut syndrome, not intractable, without status epilepticus
G40.813 Lennox-Gastaut syndrome, intractable, with status epilepticus
G40.814 Lennox-Gastaut syndrome, intractable, without status epilepticus
G40.821 Epileptic spasms, not intractable, with status epilepticus
G40.822 Epileptic spasms, not intractable, without status epilepticus
G40.823 Epileptic spasms, intractable, with status epilepticus
G40.824 Epileptic spasms, intractable, without status epilepticus
G40.89 Other seizures
G40.901 Epilepsy, unspecified, not intractable, with status epilepticus
G40.909 Epilepsy, unspecified, not intractable, without status epilepticus
G40.911 Epilepsy, unspecified, intractable, with status epilepticus
G40.919 Epilepsy, unspecified, intractable, without status epilepticus
G40.A01 Absence epileptic syndrome, not intractable, with status epilepticus
G40.A09 Absence epileptic syndrome, not intractable, without status epilepticus
G40.A11 Absence epileptic syndrome, intractable, with status epilepticus
G40.A19 Absence epileptic syndrome, intractable, without status epilepticus
G40.B01 Juvenile myoclonic epilepsy, not intractable, with status epilepticus
G40.B09 Juvenile myoclonic epilepsy, not intractable, without status epilepticus
G40.B11 Juvenile myoclonic epilepsy, intractable, with status epilepticus
G40.B19 Juvenile myoclonic epilepsy, intractable, without status epilepticus
I44.0 Atrioventricular block, first degree
I44.1 Atrioventricular block, second degree
I44.2 Atrioventricular block, complete
I44.30 Unspecified atrioventricular block
I45.81 Long QT syndrome
I47.0 Re-entry ventricular arrhythmia
I47.1 Supraventricular tachycardia
I47.2 Ventricular tachycardia
I49.2 Junctional premature depolarization
M25.50 Pain in unspecified joint
M25.59 Pain in other specified joint
M47.811 Spondylosis without myelopathy or radiculopathy, occipito-atlanto-axial region
M47.812 Spondylosis without myelopathy or radiculopathy, cervical region
M47.813 Spondylosis without myelopathy or radiculopathy, cervicothoracic region
M47.816 Spondylosis without myelopathy or radiculopathy, lumbar region
M47.817 Spondylosis without myelopathy or radiculopathy, lumbosacral region
M47.818 Spondylosis without myelopathy or radiculopathy, sacral and sacrococcygeal region
M51.14 Intervertebral disc disorders with radiculopathy, thoracic region
M51.15 Intervertebral disc disorders with radiculopathy, thoracolumbar region
M51.16 Intervertebral disc disorders with radiculopathy, lumbar region
M51.17 Intervertebral disc disorders with radiculopathy, lumbosacral region
M51.36 Other intervertebral disc degeneration, lumbar region
M51.37 Other intervertebral disc degeneration, lumbosacral region
M54.10 Radiculopathy, site unspecified
M54.14 Radiculopathy, thoracic region
M54.15 Radiculopathy, thoracolumbar region
M54.16 Radiculopathy, lumbar region
M54.17 Radiculopathy, lumbosacral region
M54.18 Radiculopathy, sacral and sacrococcygeal region
M54.2 Cervicalgia
M54.50 Low back pain, unspecified
M54.51 Vertebrogenic low back pain
M54.59 Other low back pain
M60.811 Other myositis, right shoulder
M60.812 Other myositis, left shoulder
M60.821 Other myositis, right upper arm
M60.822 Other myositis, left upper arm
M60.831 Other myositis, right forearm
M60.832 Other myositis, left forearm
M60.841 Other myositis, right hand
M60.842 Other myositis, left hand
M60.851 Other myositis, right thigh
M60.852 Other myositis, left thigh
M60.861 Other myositis, right lower leg
M60.862 Other myositis, left lower leg
M60.871 Other myositis, right ankle and foot
M60.872 Other myositis, left ankle and foot
M60.88 Other myositis, other site
M60.89 Other myositis, multiple sites
M79.11 Myalgia of mastication muscle
M79.12 Myalgia of auxiliary muscles, head and neck
M79.18 Myalgia, other site
M79.2 Neuralgia and neuritis, unspecified
M79.7 Fibromyalgia
R40.0 Somnolence
R40.1 Stupor
R40.2111 Coma scale, eyes open, never, in the field [EMT or ambulance]
R40.2112 Coma scale, eyes open, never, at arrival to emergency department
R40.2113 Coma scale, eyes open, never, at hospital admission
R40.2114 Coma scale, eyes open, never, 24 hours or more after hospital admission
R40.2121 Coma scale, eyes open, to pain, in the field [EMT or ambulance]
R40.2122 Coma scale, eyes open, to pain, at arrival to emergency department
R40.2123 Coma scale, eyes open, to pain, at hospital admission
R40.2124 Coma scale, eyes open, to pain, 24 hours or more after hospital admission
R40.2131 Coma scale, eyes open, to sound, in the field [EMT or ambulance]
R40.2132 Coma scale, eyes open, to sound, at arrival to emergency department
R40.2133 Coma scale, eyes open, to sound, at hospital admission
R40.2134 Coma scale, eyes open, to sound, 24 hours or more after hospital admission
R40.2141 Coma scale, eyes open, spontaneous, in the field [EMT or ambulance]
R40.2142 Coma scale, eyes open, spontaneous, at arrival to emergency department
R40.2143 Coma scale, eyes open, spontaneous, at hospital admission
R40.2144 Coma scale, eyes open, spontaneous, 24 hours or more after hospital admission
R40.2211 Coma scale, best verbal response, none, in the field [EMT or ambulance]
R40.2212 Coma scale, best verbal response, none, at arrival to emergency department
R40.2213 Coma scale, best verbal response, none, at hospital admission
R40.2214 Coma scale, best verbal response, none, 24 hours or more after hospital admission
R40.2221 Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance]
R40.2222 Coma scale, best verbal response, incomprehensible words, at arrival to emergency department
R40.2223 Coma scale, best verbal response, incomprehensible words, at hospital admission
R40.2224 Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admission
R40.2231 Coma scale, best verbal response, inappropriate words, in the field [EMT or ambulance]
R40.2232 Coma scale, best verbal response, inappropriate words, at arrival to emergency department
R40.2233 Coma scale, best verbal response, inappropriate words, at hospital admission
R40.2234 Coma scale, best verbal response, inappropriate words, 24 hours or more after hospital admission
R40.2241 Coma scale, best verbal response, confused conversation, in the field [EMT or ambulance]
R40.2242 Coma scale, best verbal response, confused conversation, at arrival to emergency department
R40.2243 Coma scale, best verbal response, confused conversation, at hospital admission
R40.2244 Coma scale, best verbal response, confused conversation, 24 hours or more after hospital admission
R40.2251 Coma scale, best verbal response, oriented, in the field [EMT or ambulance]
R40.2252 Coma scale, best verbal response, oriented, at arrival to emergency department
R40.2253 Coma scale, best verbal response, oriented, at hospital admission
R40.2254 Coma scale, best verbal response, oriented, 24 hours or more after hospital admission
R40.2311 Coma scale, best motor response, none, in the field [EMT or ambulance]
R40.2312 Coma scale, best motor response, none, at arrival to emergency department
R40.2313 Coma scale, best motor response, none, at hospital admission
R40.2314 Coma scale, best motor response, none, 24 hours or more after hospital admission
R40.2321 Coma scale, best motor response, extension, in the field [EMT or ambulance]
R40.2322 Coma scale, best motor response, extension, at arrival to emergency department
R40.2323 Coma scale, best motor response, extension, at hospital admission
R40.2324 Coma scale, best motor response, extension, 24 hours or more after hospital admission
R40.2331 Coma scale, best motor response, abnormal flexion, in the field [EMT or ambulance]
R40.2332 Coma scale, best motor response, abnormal flexion, at arrival to emergency department
R40.2333 Coma scale, best motor response, abnormal flexion, at hospital admission
R40.2334 Coma scale, best motor response, abnormal flexion, 24 hours or more after hospital admission
R40.2341 Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance]
R40.2342 Coma scale, best motor response, flexion withdrawal, at arrival to emergency department
R40.2343 Coma scale, best motor response, flexion withdrawal, at hospital admission
R40.2344 Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission
R40.2351 Coma scale, best motor response, localizes pain, in the field [EMT or ambulance]
R40.2352 Coma scale, best motor response, localizes pain, at arrival to emergency department
R40.2353 Coma scale, best motor response, localizes pain, at hospital admission
R40.2354 Coma scale, best motor response, localizes pain, 24 hours or more after hospital admission
R40.2361 Coma scale, best motor response, obeys commands, in the field [EMT or ambulance]
R40.2362 Coma scale, best motor response, obeys commands, at arrival to emergency department
R40.2363 Coma scale, best motor response, obeys commands, at hospital admission
R40.2364 Coma scale, best motor response, obeys commands, 24 hours or more after hospital admission
R40.2410 Glasgow coma scale score 13-15, unspecified time
R40.2411 Glasgow coma scale score 13-15, in the field [EMT or ambulance]
R40.2412 Glasgow coma scale score 13-15, at arrival to emergency department
R40.2413 Glasgow coma scale score 13-15, at hospital admission
R40.2414 Glasgow coma scale score 13-15, 24 hours or more after hospital admission
R40.2420 Glasgow coma scale score 9-12, unspecified time
R40.2421 Glasgow coma scale score 9-12, in the field [EMT or ambulance]
R40.2422 Glasgow coma scale score 9-12, at arrival to emergency department
R40.2423 Glasgow coma scale score 9-12, at hospital admission
R40.2424 Glasgow coma scale score 9-12, 24 hours or more after hospital admission
R40.2430 Glasgow coma scale score 3-8, unspecified time
R40.2431 Glasgow coma scale score 3-8, in the field [EMT or ambulance]
R40.2432 Glasgow coma scale score 3-8, at arrival to emergency department
R40.2433 Glasgow coma scale score 3-8, at hospital admission
R40.2434 Glasgow coma scale score 3-8, 24 hours or more after hospital admission
R40.2440 Other coma, without documented Glasgow coma scale score, or with partial score reported, unspecified time
R40.2441 Other coma, without documented Glasgow coma scale score, or with partial score reported, in the field [EMT or ambulance]
R40.2442 Other coma, without documented Glasgow coma scale score, or with partial score reported, at arrival to emergency department
R40.2443 Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission
R40.2444 Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission
R41.0 Disorientation, unspecified
R41.82 Altered mental status, unspecified
R44.0 Auditory hallucinations
R44.3 Hallucinations, unspecified
R56.00 Simple febrile convulsions
R56.01 Complex febrile convulsions
R56.1 Post traumatic seizures
R56.9 Unspecified convulsions
T39.011A Poisoning by aspirin, accidental (unintentional), initial encounter
T39.011D Poisoning by aspirin, accidental (unintentional), subsequent encounter
T39.012A Poisoning by aspirin, intentional self-harm, initial encounter
T39.012D Poisoning by aspirin, intentional self-harm, subsequent encounter
T39.013A Poisoning by aspirin, assault, initial encounter
T39.013D Poisoning by aspirin, assault, subsequent encounter
T39.014A Poisoning by aspirin, undetermined, initial encounter
T39.014D Poisoning by aspirin, undetermined, subsequent encounter
T39.015A Adverse effect of aspirin, initial encounter
T39.015D Adverse effect of aspirin, subsequent encounter
T39.016A Underdosing of aspirin, initial encounter
T39.016D Underdosing of aspirin, subsequent encounter
T39.091A Poisoning by salicylates, accidental (unintentional), initial encounter
T39.091D Poisoning by salicylates, accidental (unintentional), subsequent encounter
T39.092A Poisoning by salicylates, intentional self-harm, initial encounter
T39.092D Poisoning by salicylates, intentional self-harm, subsequent encounter
T39.093A Poisoning by salicylates, assault, initial encounter
T39.093D Poisoning by salicylates, assault, subsequent encounter
T39.094A Poisoning by salicylates, undetermined, initial encounter
T39.094D Poisoning by salicylates, undetermined, subsequent encounter
T39.095A Adverse effect of salicylates, initial encounter
T39.095D Adverse effect of salicylates, subsequent encounter
T39.096A Underdosing of salicylates, initial encounter
T39.096D Underdosing of salicylates, subsequent encounter
T39.1X1A Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter
T39.1X1D Poisoning by 4-Aminophenol derivatives, accidental (unintentional), subsequent encounter
T39.1X2A Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter
T39.1X2D Poisoning by 4-Aminophenol derivatives, intentional self-harm, subsequent encounter
T39.1X3A Poisoning by 4-Aminophenol derivatives, assault, initial encounter
T39.1X3D Poisoning by 4-Aminophenol derivatives, assault, subsequent encounter
T39.1X4A Poisoning by 4-Aminophenol derivatives, undetermined, initial encounter
T39.1X4D Poisoning by 4-Aminophenol derivatives, undetermined, subsequent encounter
T39.1X5A Adverse effect of 4-Aminophenol derivatives, initial encounter
T39.1X5D Adverse effect of 4-Aminophenol derivatives, subsequent encounter
T39.1X6A Underdosing of 4-Aminophenol derivatives, initial encounter
T39.1X6D Underdosing of 4-Aminophenol derivatives, subsequent encounter
T39.2X1A Poisoning by pyrazolone derivatives, accidental (unintentional), initial encounter
T39.2X1D Poisoning by pyrazolone derivatives, accidental (unintentional), subsequent encounter
T39.2X2A Poisoning by pyrazolone derivatives, intentional self-harm, initial encounter
T39.2X2D Poisoning by pyrazolone derivatives, intentional self-harm, subsequent encounter
T39.2X3A Poisoning by pyrazolone derivatives, assault, initial encounter
T39.2X3D Poisoning by pyrazolone derivatives, assault, subsequent encounter
T39.2X4A Poisoning by pyrazolone derivatives, undetermined, initial encounter
T39.2X4D Poisoning by pyrazolone derivatives, undetermined, subsequent encounter
T39.2X5A Adverse effect of pyrazolone derivatives, initial encounter
T39.2X5D Adverse effect of pyrazolone derivatives, subsequent encounter
T39.311A Poisoning by propionic acid derivatives, accidental (unintentional), initial encounter
T39.311D Poisoning by propionic acid derivatives, accidental (unintentional), subsequent encounter
T39.312A Poisoning by propionic acid derivatives, intentional self-harm, initial encounter
T39.312D Poisoning by propionic acid derivatives, intentional self-harm, subsequent encounter
T39.313A Poisoning by propionic acid derivatives, assault, initial encounter
T39.313D Poisoning by propionic acid derivatives, assault, subsequent encounter
T39.314A Poisoning by propionic acid derivatives, undetermined, initial encounter
T39.314D Poisoning by propionic acid derivatives, undetermined, subsequent encounter
T39.315A Adverse effect of propionic acid derivatives, initial encounter
T39.315D Adverse effect of propionic acid derivatives, subsequent encounter
T39.316A Underdosing of propionic acid derivatives, initial encounter
T39.316D Underdosing of propionic acid derivatives, subsequent encounter
T39.391A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), initial encounter
T39.391D Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), subsequent encounter
T39.392A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, initial encounter
T39.392D Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, subsequent encounter
T39.393A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, initial encounter
T39.393D Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, subsequent encounter
T39.394A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, initial encounter
T39.394D Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, subsequent encounter
T39.395A Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
T39.395D Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
T39.396A Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
T39.396D Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
T40.0X1A Poisoning by opium, accidental (unintentional), initial encounter
T40.0X1D Poisoning by opium, accidental (unintentional), subsequent encounter
T40.0X2A Poisoning by opium, intentional self-harm, initial encounter
T40.0X2D Poisoning by opium, intentional self-harm, subsequent encounter
T40.0X3A Poisoning by opium, assault, initial encounter
T40.0X3D Poisoning by opium, assault, subsequent encounter
T40.0X4A Poisoning by opium, undetermined, initial encounter
T40.0X4D Poisoning by opium, undetermined, subsequent encounter
T40.0X5A Adverse effect of opium, initial encounter
T40.0X5D Adverse effect of opium, subsequent encounter
T40.0X6A Underdosing of opium, initial encounter
T40.0X6D Underdosing of opium, subsequent encounter
T40.1X1A Poisoning by heroin, accidental (unintentional), initial encounter
T40.1X1D Poisoning by heroin, accidental (unintentional), subsequent encounter
T40.1X2A Poisoning by heroin, intentional self-harm, initial encounter
T40.1X2D Poisoning by heroin, intentional self-harm, subsequent encounter
T40.1X3A Poisoning by heroin, assault, initial encounter
T40.1X3D Poisoning by heroin, assault, subsequent encounter
T40.1X4A Poisoning by heroin, undetermined, initial encounter
T40.1X4D Poisoning by heroin, undetermined, subsequent encounter
T40.2X1A Poisoning by other opioids, accidental (unintentional), initial encounter
T40.2X1D Poisoning by other opioids, accidental (unintentional), subsequent encounter
T40.2X2A Poisoning by other opioids, intentional self-harm, initial encounter
T40.2X2D Poisoning by other opioids, intentional self-harm, subsequent encounter
T40.2X3A Poisoning by other opioids, assault, initial encounter
T40.2X3D Poisoning by other opioids, assault, subsequent encounter
T40.2X4A Poisoning by other opioids, undetermined, initial encounter
T40.2X4D Poisoning by other opioids, undetermined, subsequent encounter
T40.2X5A Adverse effect of other opioids, initial encounter
T40.2X5D Adverse effect of other opioids, subsequent encounter
T40.2X6A Underdosing of other opioids, initial encounter
T40.2X6D Underdosing of other opioids, subsequent encounter
T40.3X1A Poisoning by methadone, accidental (unintentional), initial encounter
T40.3X1D Poisoning by methadone, accidental (unintentional), subsequent encounter
T40.3X2A Poisoning by methadone, intentional self-harm, initial encounter
T40.3X2D Poisoning by methadone, intentional self-harm, subsequent encounter
T40.3X3A Poisoning by methadone, assault, initial encounter
T40.3X3D Poisoning by methadone, assault, subsequent encounter
T40.3X4A Poisoning by methadone, undetermined, initial encounter
T40.3X4D Poisoning by methadone, undetermined, subsequent encounter
T40.3X5A Adverse effect of methadone, initial encounter
T40.3X5D Adverse effect of methadone, subsequent encounter
T40.3X6A Underdosing of methadone, initial encounter
T40.3X6D Underdosing of methadone, subsequent encounter
T40.491A Poisoning by other synthetic narcotics, accidental (unintentional), initial encounter
T40.491D Poisoning by other synthetic narcotics, accidental (unintentional), subsequent encounter
T40.492A Poisoning by other synthetic narcotics, intentional self-harm, initial encounter
T40.492D Poisoning by other synthetic narcotics, intentional self-harm, subsequent encounter
T40.493A Poisoning by other synthetic narcotics, assault, initial encounter
T40.493D Poisoning by other synthetic narcotics, assault, subsequent encounter
T40.494A Poisoning by other synthetic narcotics, undetermined, initial encounter
T40.494D Poisoning by other synthetic narcotics, undetermined, subsequent encounter
T40.495A Adverse effect of other synthetic narcotics, initial encounter
T40.495D Adverse effect of other synthetic narcotics, subsequent encounter
T40.496A Underdosing of other synthetic narcotics, initial encounter
T40.496D Underdosing of other synthetic narcotics, subsequent encounter
T40.5X1A Poisoning by cocaine, accidental (unintentional), initial encounter
T40.5X1D Poisoning by cocaine, accidental (unintentional), subsequent encounter
T40.5X2A Poisoning by cocaine, intentional self-harm, initial encounter
T40.5X2D Poisoning by cocaine, intentional self-harm, subsequent encounter
T40.5X3A Poisoning by cocaine, assault, initial encounter
T40.5X3D Poisoning by cocaine, assault, subsequent encounter
T40.5X4A Poisoning by cocaine, undetermined, initial encounter
T40.5X4D Poisoning by cocaine, undetermined, subsequent encounter
T40.5X5A Adverse effect of cocaine, initial encounter
T40.5X5D Adverse effect of cocaine, subsequent encounter
T40.5X6A Underdosing of cocaine, initial encounter
T40.5X6D Underdosing of cocaine, subsequent encounter
T40.601A Poisoning by unspecified narcotics, accidental (unintentional), initial encounter
T40.601D Poisoning by unspecified narcotics, accidental (unintentional), subsequent encounter
T40.602A Poisoning by unspecified narcotics, intentional self-harm, initial encounter
T40.602D Poisoning by unspecified narcotics, intentional self-harm, subsequent encounter
T40.603A Poisoning by unspecified narcotics, assault, initial encounter
T40.603D Poisoning by unspecified narcotics, assault, subsequent encounter
T40.604A Poisoning by unspecified narcotics, undetermined, initial encounter
T40.604D Poisoning by unspecified narcotics, undetermined, subsequent encounter
T40.605A Adverse effect of unspecified narcotics, initial encounter
T40.605D Adverse effect of unspecified narcotics, subsequent encounter
T40.606A Underdosing of unspecified narcotics, initial encounter
T40.606D Underdosing of unspecified narcotics, subsequent encounter
T40.691A Poisoning by other narcotics, accidental (unintentional), initial encounter
T40.691D Poisoning by other narcotics, accidental (unintentional), subsequent encounter
T40.692A Poisoning by other narcotics, intentional self-harm, initial encounter
T40.692D Poisoning by other narcotics, intentional self-harm, subsequent encounter
T40.693A Poisoning by other narcotics, assault, initial encounter
T40.693D Poisoning by other narcotics, assault, subsequent encounter
T40.694A Poisoning by other narcotics, undetermined, initial encounter
T40.694D Poisoning by other narcotics, undetermined, subsequent encounter
T40.695A Adverse effect of other narcotics, initial encounter
T40.695D Adverse effect of other narcotics, subsequent encounter
T40.696A Underdosing of other narcotics, initial encounter
T40.696D Underdosing of other narcotics, subsequent encounter
T40.711A Poisoning by cannabis, accidental (unintentional), initial encounter
T40.711D Poisoning by cannabis, accidental (unintentional), subsequent encounter
T40.712A Poisoning by cannabis, intentional self-harm, initial encounter
T40.712D Poisoning by cannabis, intentional self-harm, subsequent encounter
T40.713A Poisoning by cannabis, assault, initial encounter
T40.713D Poisoning by cannabis, assault, subsequent encounter
T40.714A Poisoning by cannabis, undetermined, initial encounter
T40.714D Poisoning by cannabis, undetermined, subsequent encounter
T40.715A Adverse effect of cannabis, initial encounter
T40.715D Adverse effect of cannabis, subsequent encounter
T40.716A Underdosing of cannabis, initial encounter
T40.716D Underdosing of cannabis, subsequent encounter
T40.721A Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter
T40.721D Poisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter
T40.722A Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter
T40.722D Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter
T40.723A Poisoning by synthetic cannabinoids, assault, initial encounter
T40.723D Poisoning by synthetic cannabinoids, assault, subsequent encounter
T40.724A Poisoning by synthetic cannabinoids, undetermined, initial encounter
T40.724D Poisoning by synthetic cannabinoids, undetermined, subsequent encounter
T40.725A Adverse effect of synthetic cannabinoids, initial encounter
T40.725D Adverse effect of synthetic cannabinoids, subsequent encounter
T40.726A Underdosing of synthetic cannabinoids, initial encounter
T40.726D Underdosing of synthetic cannabinoids, subsequent encounter
T40.8X1A Poisoning by lysergide [LSD], accidental (unintentional), initial encounter
T40.8X1D Poisoning by lysergide [LSD], accidental (unintentional), subsequent encounter
T40.8X2A Poisoning by lysergide [LSD], intentional self-harm, initial encounter
T40.8X2D Poisoning by lysergide [LSD], intentional self-harm, subsequent encounter
T40.8X4A Poisoning by lysergide [LSD], undetermined, initial encounter
T40.8X4D Poisoning by lysergide [LSD], undetermined, subsequent encounter
T40.901A Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
T40.901D Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter
T40.902A Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, initial encounter
T40.902D Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter
T40.903A Poisoning by unspecified psychodysleptics [hallucinogens], assault, initial encounter
T40.903D Poisoning by unspecified psychodysleptics [hallucinogens], assault, subsequent encounter
T40.904A Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, initial encounter
T40.904D Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, subsequent encounter
T40.905A Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
T40.905D Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
T40.906A Underdosing of unspecified psychodysleptics [hallucinogens], initial encounter
T40.906D Underdosing of unspecified psychodysleptics [hallucinogens], subsequent encounter
T40.991A Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
T40.991D Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter
T40.992A Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter
T40.992D Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter
T40.993A Poisoning by other psychodysleptics [hallucinogens], assault, initial encounter
T40.993D Poisoning by other psychodysleptics [hallucinogens], assault, subsequent encounter
T40.994A Poisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter
T40.994D Poisoning by other psychodysleptics [hallucinogens], undetermined, subsequent encounter
T40.995A Adverse effect of other psychodysleptics [hallucinogens], initial encounter
T40.995D Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter
T40.996A Underdosing of other psychodysleptics [hallucinogens], initial encounter
T40.996D Underdosing of other psychodysleptics [hallucinogens], subsequent encounter
T42.0X1A Poisoning by hydantoin derivatives, accidental (unintentional), initial encounter
T42.0X1D Poisoning by hydantoin derivatives, accidental (unintentional), subsequent encounter
T42.0X2A Poisoning by hydantoin derivatives, intentional self-harm, initial encounter
T42.0X2D Poisoning by hydantoin derivatives, intentional self-harm, subsequent encounter
T42.0X3A Poisoning by hydantoin derivatives, assault, initial encounter
T42.0X3D Poisoning by hydantoin derivatives, assault, subsequent encounter
T42.0X4A Poisoning by hydantoin derivatives, undetermined, initial encounter
T42.0X4D Poisoning by hydantoin derivatives, undetermined, subsequent encounter
T42.0X5A Adverse effect of hydantoin derivatives, initial encounter
T42.0X5D Adverse effect of hydantoin derivatives, subsequent encounter
T42.0X6A Underdosing of hydantoin derivatives, initial encounter
T42.0X6D Underdosing of hydantoin derivatives, subsequent encounter
T42.3X1A Poisoning by barbiturates, accidental (unintentional), initial encounter
T42.3X1D Poisoning by barbiturates, accidental (unintentional), subsequent encounter
T42.3X2A Poisoning by barbiturates, intentional self-harm, initial encounter
T42.3X2D Poisoning by barbiturates, intentional self-harm, subsequent encounter
T42.3X3A Poisoning by barbiturates, assault, initial encounter
T42.3X3D Poisoning by barbiturates, assault, subsequent encounter
T42.3X4A Poisoning by barbiturates, undetermined, initial encounter
T42.3X4D Poisoning by barbiturates, undetermined, subsequent encounter
T42.3X5A Adverse effect of barbiturates, initial encounter
T42.3X5D Adverse effect of barbiturates, subsequent encounter
T42.3X6A Underdosing of barbiturates, initial encounter
T42.3X6D Underdosing of barbiturates, subsequent encounter
T42.4X1A Poisoning by benzodiazepines, accidental (unintentional), initial encounter
T42.4X1D Poisoning by benzodiazepines, accidental (unintentional), subsequent encounter
T42.4X2A Poisoning by benzodiazepines, intentional self-harm, initial encounter
T42.4X2D Poisoning by benzodiazepines, intentional self-harm, subsequent encounter
T42.4X3A Poisoning by benzodiazepines, assault, initial encounter
T42.4X3D Poisoning by benzodiazepines, assault, subsequent encounter
T42.4X4A Poisoning by benzodiazepines, undetermined, initial encounter
T42.4X4D Poisoning by benzodiazepines, undetermined, subsequent encounter
T42.4X5A Adverse effect of benzodiazepines, initial encounter
T42.4X5D Adverse effect of benzodiazepines, subsequent encounter
T42.4X6A Underdosing of benzodiazepines, initial encounter
T42.4X6D Underdosing of benzodiazepines, subsequent encounter
T42.6X1A Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter
T42.6X1D Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), subsequent encounter
T42.6X2A Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter
T42.6X2D Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, subsequent encounter
T42.6X3A Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, initial encounter
T42.6X3D Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, subsequent encounter
T42.6X4A Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter
T42.6X4D Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, subsequent encounter
T42.6X5A Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
T42.6X5D Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
T42.6X6A Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter
T42.6X6D Underdosing of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
T42.71XA Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter
T42.71XD Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional), subsequent encounter
T42.72XA Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter
T42.72XD Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, subsequent encounter
T42.73XA Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault, initial encounter
T42.73XD Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault, subsequent encounter
T42.74XA Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter
T42.74XD Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, subsequent encounter
T42.75XA Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
T42.75XD Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
T42.76XA Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
T42.76XD Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
T43.011A Poisoning by tricyclic antidepressants, accidental (unintentional), initial encounter
T43.011D Poisoning by tricyclic antidepressants, accidental (unintentional), subsequent encounter
T43.012A Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter
T43.012D Poisoning by tricyclic antidepressants, intentional self-harm, subsequent encounter
T43.013A Poisoning by tricyclic antidepressants, assault, initial encounter
T43.013D Poisoning by tricyclic antidepressants, assault, subsequent encounter
T43.014A Poisoning by tricyclic antidepressants, undetermined, initial encounter
T43.014D Poisoning by tricyclic antidepressants, undetermined, subsequent encounter
T43.015A Adverse effect of tricyclic antidepressants, initial encounter
T43.015D Adverse effect of tricyclic antidepressants, subsequent encounter
T43.016A Underdosing of tricyclic antidepressants, initial encounter
T43.016D Underdosing of tricyclic antidepressants, subsequent encounter
T43.021A Poisoning by tetracyclic antidepressants, accidental (unintentional), initial encounter
T43.021D Poisoning by tetracyclic antidepressants, accidental (unintentional), subsequent encounter
T43.022A Poisoning by tetracyclic antidepressants, intentional self-harm, initial encounter
T43.022D Poisoning by tetracyclic antidepressants, intentional self-harm, subsequent encounter
T43.023A Poisoning by tetracyclic antidepressants, assault, initial encounter
T43.023D Poisoning by tetracyclic antidepressants, assault, subsequent encounter
T43.024A Poisoning by tetracyclic antidepressants, undetermined, initial encounter
T43.024D Poisoning by tetracyclic antidepressants, undetermined, subsequent encounter
T43.025A Adverse effect of tetracyclic antidepressants, initial encounter
T43.025D Adverse effect of tetracyclic antidepressants, subsequent encounter
T43.026A Underdosing of tetracyclic antidepressants, initial encounter
T43.026D Underdosing of tetracyclic antidepressants, subsequent encounter
T43.1X1A Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), initial encounter
T43.1X1D Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), subsequent encounter
T43.1X2A Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounter
T43.1X2D Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, subsequent encounter
T43.1X3A Poisoning by monoamine-oxidase-inhibitor antidepressants, assault, initial encounter
T43.1X3D Poisoning by monoamine-oxidase-inhibitor antidepressants, assault, subsequent encounter
T43.1X4A Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, initial encounter
T43.1X4D Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, subsequent encounter
T43.1X5A Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
T43.1X5D Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
T43.1X6A Underdosing of monoamine-oxidase-inhibitor antidepressants, initial encounter
T43.1X6D Underdosing of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
T43.201A Poisoning by unspecified antidepressants, accidental (unintentional), initial encounter
T43.201D Poisoning by unspecified antidepressants, accidental (unintentional), subsequent encounter
T43.202A Poisoning by unspecified antidepressants, intentional self-harm, initial encounter
T43.202D Poisoning by unspecified antidepressants, intentional self-harm, subsequent encounter
T43.203A Poisoning by unspecified antidepressants, assault, initial encounter
T43.203D Poisoning by unspecified antidepressants, assault, subsequent encounter
T43.204A Poisoning by unspecified antidepressants, undetermined, initial encounter
T43.204D Poisoning by unspecified antidepressants, undetermined, subsequent encounter
T43.205A Adverse effect of unspecified antidepressants, initial encounter
T43.205D Adverse effect of unspecified antidepressants, subsequent encounter
T43.206A Underdosing of unspecified antidepressants, initial encounter
T43.206D Underdosing of unspecified antidepressants, subsequent encounter
T43.211A Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), initial encounter
T43.211D Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), subsequent encounter
T43.212A Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter
T43.212D Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, subsequent encounter
T43.213A Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, initial encounter
T43.213D Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, subsequent encounter
T43.214A Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, initial encounter
T43.214D Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, subsequent encounter
T43.215A Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
T43.215D Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
T43.216A Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
T43.216D Underdosing of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
T43.221A Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), initial encounter
T43.221D Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), subsequent encounter
T43.222A Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter
T43.222D Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, subsequent encounter
T43.223A Poisoning by selective serotonin reuptake inhibitors, assault, initial encounter
T43.223D Poisoning by selective serotonin reuptake inhibitors, assault, subsequent encounter
T43.224A Poisoning by selective serotonin reuptake inhibitors, undetermined, initial encounter
T43.224D Poisoning by selective serotonin reuptake inhibitors, undetermined, subsequent encounter
T43.225A Adverse effect of selective serotonin reuptake inhibitors, initial encounter
T43.225D Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter
T43.226A Underdosing of selective serotonin reuptake inhibitors, initial encounter
T43.226D Underdosing of selective serotonin reuptake inhibitors, subsequent encounter
T43.291A Poisoning by other antidepressants, accidental (unintentional), initial encounter
T43.291D Poisoning by other antidepressants, accidental (unintentional), subsequent encounter
T43.292A Poisoning by other antidepressants, intentional self-harm, initial encounter
T43.292D Poisoning by other antidepressants, intentional self-harm, subsequent encounter
T43.293A Poisoning by other antidepressants, assault, initial encounter
T43.293D Poisoning by other antidepressants, assault, subsequent encounter
T43.294A Poisoning by other antidepressants, undetermined, initial encounter
T43.294D Poisoning by other antidepressants, undetermined, subsequent encounter
T43.295A Adverse effect of other antidepressants, initial encounter
T43.295D Adverse effect of other antidepressants, subsequent encounter
T43.296A Underdosing of other antidepressants, initial encounter
T43.296D Underdosing of other antidepressants, subsequent encounter
T43.3X1A Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T43.3X1D Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter
T43.3X2A Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, initial encounter
T43.3X2D Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, subsequent encounter
T43.3X3A Poisoning by phenothiazine antipsychotics and neuroleptics, assault, initial encounter
T43.3X3D Poisoning by phenothiazine antipsychotics and neuroleptics, assault, subsequent encounter
T43.3X4A Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, initial encounter
T43.3X4D Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, subsequent encounter
T43.3X5A Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
T43.3X5D Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
T43.3X6A Underdosing of phenothiazine antipsychotics and neuroleptics, initial encounter
T43.3X6D Underdosing of phenothiazine antipsychotics and neuroleptics, subsequent encounter
T43.4X1A Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), initial encounter
T43.4X1D Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), subsequent encounter
T43.4X2A Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, initial encounter
T43.4X2D Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, subsequent encounter
T43.4X3A Poisoning by butyrophenone and thiothixene neuroleptics, assault, initial encounter
T43.4X3D Poisoning by butyrophenone and thiothixene neuroleptics, assault, subsequent encounter
T43.4X4A Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, initial encounter
T43.4X4D Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, subsequent encounter
T43.4X5A Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
T43.4X5D Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
T43.4X6A Underdosing of butyrophenone and thiothixene neuroleptics, initial encounter
T43.4X6D Underdosing of butyrophenone and thiothixene neuroleptics, subsequent encounter
T43.501A Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T43.501D Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter
T43.502A Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, initial encounter
T43.502D Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, subsequent encounter
T43.503A Poisoning by unspecified antipsychotics and neuroleptics, assault, initial encounter
T43.503D Poisoning by unspecified antipsychotics and neuroleptics, assault, subsequent encounter
T43.504A Poisoning by unspecified antipsychotics and neuroleptics, undetermined, initial encounter
T43.504D Poisoning by unspecified antipsychotics and neuroleptics, undetermined, subsequent encounter
T43.505A Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter
T43.505D Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter
T43.506A Underdosing of unspecified antipsychotics and neuroleptics, initial encounter
T43.506D Underdosing of unspecified antipsychotics and neuroleptics, subsequent encounter
T43.591A Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T43.591D Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter
T43.592A Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter
T43.592D Poisoning by other antipsychotics and neuroleptics, intentional self-harm, subsequent encounter
T43.593A Poisoning by other antipsychotics and neuroleptics, assault, initial encounter
T43.593D Poisoning by other antipsychotics and neuroleptics, assault, subsequent encounter
T43.594A Poisoning by other antipsychotics and neuroleptics, undetermined, initial encounter
T43.594D Poisoning by other antipsychotics and neuroleptics, undetermined, subsequent encounter
T43.595A Adverse effect of other antipsychotics and neuroleptics, initial encounter
T43.595D Adverse effect of other antipsychotics and neuroleptics, subsequent encounter
T43.596A Underdosing of other antipsychotics and neuroleptics, initial encounter
T43.596D Underdosing of other antipsychotics and neuroleptics, subsequent encounter
T43.601A Poisoning by unspecified psychostimulants, accidental (unintentional), initial encounter
T43.601D Poisoning by unspecified psychostimulants, accidental (unintentional), subsequent encounter
T43.602A Poisoning by unspecified psychostimulants, intentional self-harm, initial encounter
T43.602D Poisoning by unspecified psychostimulants, intentional self-harm, subsequent encounter
T43.603A Poisoning by unspecified psychostimulants, assault, initial encounter
T43.603D Poisoning by unspecified psychostimulants, assault, subsequent encounter
T43.604A Poisoning by unspecified psychostimulants, undetermined, initial encounter
T43.604D Poisoning by unspecified psychostimulants, undetermined, subsequent encounter
T43.605A Adverse effect of unspecified psychostimulants, initial encounter
T43.605D Adverse effect of unspecified psychostimulants, subsequent encounter
T43.606A Underdosing of unspecified psychostimulants, initial encounter
T43.606D Underdosing of unspecified psychostimulants, subsequent encounter
T43.611A Poisoning by caffeine, accidental (unintentional), initial encounter
T43.611D Poisoning by caffeine, accidental (unintentional), subsequent encounter
T43.612A Poisoning by caffeine, intentional self-harm, initial encounter
T43.612D Poisoning by caffeine, intentional self-harm, subsequent encounter
T43.613A Poisoning by caffeine, assault, initial encounter
T43.613D Poisoning by caffeine, assault, subsequent encounter
T43.614A Poisoning by caffeine, undetermined, initial encounter
T43.614D Poisoning by caffeine, undetermined, subsequent encounter
T43.615A Adverse effect of caffeine, initial encounter
T43.615D Adverse effect of caffeine, subsequent encounter
T43.616A Underdosing of caffeine, initial encounter
T43.616D Underdosing of caffeine, subsequent encounter
T43.621A Poisoning by amphetamines, accidental (unintentional), initial encounter
T43.621D Poisoning by amphetamines, accidental (unintentional), subsequent encounter
T43.622A Poisoning by amphetamines, intentional self-harm, initial encounter
T43.622D Poisoning by amphetamines, intentional self-harm, subsequent encounter
T43.623A Poisoning by amphetamines, assault, initial encounter
T43.623D Poisoning by amphetamines, assault, subsequent encounter
T43.624A Poisoning by amphetamines, undetermined, initial encounter
T43.624D Poisoning by amphetamines, undetermined, subsequent encounter
T43.625A Adverse effect of amphetamines, initial encounter
T43.625D Adverse effect of amphetamines, subsequent encounter
T43.626A Underdosing of amphetamines, initial encounter
T43.626D Underdosing of amphetamines, subsequent encounter
T43.631A Poisoning by methylphenidate, accidental (unintentional), initial encounter
T43.631D Poisoning by methylphenidate, accidental (unintentional), subsequent encounter
T43.632A Poisoning by methylphenidate, intentional self-harm, initial encounter
T43.632D Poisoning by methylphenidate, intentional self-harm, subsequent encounter
T43.633A Poisoning by methylphenidate, assault, initial encounter
T43.633D Poisoning by methylphenidate, assault, subsequent encounter
T43.634A Poisoning by methylphenidate, undetermined, initial encounter
T43.634D Poisoning by methylphenidate, undetermined, subsequent encounter
T43.635A Adverse effect of methylphenidate, initial encounter
T43.635D Adverse effect of methylphenidate, subsequent encounter
T43.636A Underdosing of methylphenidate, initial encounter
T43.636D Underdosing of methylphenidate, subsequent encounter
T43.641A Poisoning by ecstasy, accidental (unintentional), initial encounter
T43.641D Poisoning by ecstasy, accidental (unintentional), subsequent encounter
T43.642A Poisoning by ecstasy, intentional self-harm, initial encounter
T43.642D Poisoning by ecstasy, intentional self-harm, subsequent encounter
T43.643A Poisoning by ecstasy, assault, initial encounter
T43.643D Poisoning by ecstasy, assault, subsequent encounter
T43.644A Poisoning by ecstasy, undetermined, initial encounter
T43.644D Poisoning by ecstasy, undetermined, subsequent encounter
T43.691A Poisoning by other psychostimulants, accidental (unintentional), initial encounter
T43.691D Poisoning by other psychostimulants, accidental (unintentional), subsequent encounter
T43.692A Poisoning by other psychostimulants, intentional self-harm, initial encounter
T43.692D Poisoning by other psychostimulants, intentional self-harm, subsequent encounter
T43.693A Poisoning by other psychostimulants, assault, initial encounter
T43.693D Poisoning by other psychostimulants, assault, subsequent encounter
T43.694A Poisoning by other psychostimulants, undetermined, initial encounter
T43.694D Poisoning by other psychostimulants, undetermined, subsequent encounter
T43.695A Adverse effect of other psychostimulants, initial encounter
T43.695D Adverse effect of other psychostimulants, subsequent encounter
T43.696A Underdosing of other psychostimulants, initial encounter
T43.696D Underdosing of other psychostimulants, subsequent encounter
T43.8X1A Poisoning by other psychotropic drugs, accidental (unintentional), initial encounter
T43.8X1D Poisoning by other psychotropic drugs, accidental (unintentional), subsequent encounter
T43.8X2A Poisoning by other psychotropic drugs, intentional self-harm, initial encounter
T43.8X2D Poisoning by other psychotropic drugs, intentional self-harm, subsequent encounter
T43.8X3A Poisoning by other psychotropic drugs, assault, initial encounter
T43.8X3D Poisoning by other psychotropic drugs, assault, subsequent encounter
T43.8X4A Poisoning by other psychotropic drugs, undetermined, initial encounter
T43.8X4D Poisoning by other psychotropic drugs, undetermined, subsequent encounter
T43.8X5A Adverse effect of other psychotropic drugs, initial encounter
T43.8X5D Adverse effect of other psychotropic drugs, subsequent encounter
T43.8X6A Underdosing of other psychotropic drugs, initial encounter
T43.8X6D Underdosing of other psychotropic drugs, subsequent encounter
T43.91XA Poisoning by unspecified psychotropic drug, accidental (unintentional), initial encounter
T43.91XD Poisoning by unspecified psychotropic drug, accidental (unintentional), subsequent encounter
T43.92XA Poisoning by unspecified psychotropic drug, intentional self-harm, initial encounter
T43.92XD Poisoning by unspecified psychotropic drug, intentional self-harm, subsequent encounter
T43.93XA Poisoning by unspecified psychotropic drug, assault, initial encounter
T43.93XD Poisoning by unspecified psychotropic drug, assault, subsequent encounter
T43.94XA Poisoning by unspecified psychotropic drug, undetermined, initial encounter
T43.94XD Poisoning by unspecified psychotropic drug, undetermined, subsequent encounter
T43.95XA Adverse effect of unspecified psychotropic drug, initial encounter
T43.95XD Adverse effect of unspecified psychotropic drug, subsequent encounter
T43.96XA Underdosing of unspecified psychotropic drug, initial encounter
T43.96XD Underdosing of unspecified psychotropic drug, subsequent encounter
T45.0X1A Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
T45.0X1D Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), subsequent encounter
T45.0X2A Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
T45.0X2D Poisoning by antiallergic and antiemetic drugs, intentional self-harm, subsequent encounter
T45.0X3A Poisoning by antiallergic and antiemetic drugs, assault, initial encounter
T45.0X3D Poisoning by antiallergic and antiemetic drugs, assault, subsequent encounter
T45.0X4A Poisoning by antiallergic and antiemetic drugs, undetermined, initial encounter
T45.0X4D Poisoning by antiallergic and antiemetic drugs, undetermined, subsequent encounter
T45.0X5A Adverse effect of antiallergic and antiemetic drugs, initial encounter
T45.0X5D Adverse effect of antiallergic and antiemetic drugs, subsequent encounter
T45.0X6A Underdosing of antiallergic and antiemetic drugs, initial encounter
T45.0X6D Underdosing of antiallergic and antiemetic drugs, subsequent encounter
T46.0X1A Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
T46.0X1D Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
T46.0X2A Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
T46.0X2D Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
T46.0X3A Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
T46.0X3D Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
T46.0X4A Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
T46.0X4D Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
T46.0X5A Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T46.0X5D Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T46.0X6A Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T46.0X6D Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T50.901A Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
T50.901D Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), subsequent encounter
T50.902A Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
T50.902D Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, subsequent encounter
T50.903A Poisoning by unspecified drugs, medicaments and biological substances, assault, initial encounter
T50.903D Poisoning by unspecified drugs, medicaments and biological substances, assault, subsequent encounter
T50.904A Poisoning by unspecified drugs, medicaments and biological substances, undetermined, initial encounter
T50.904D Poisoning by unspecified drugs, medicaments and biological substances, undetermined, subsequent encounter
T50.905A Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
T50.905D Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter
T50.906A Underdosing of unspecified drugs, medicaments and biological substances, initial encounter
T50.906D Underdosing of unspecified drugs, medicaments and biological substances, subsequent encounter
T50.911A Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
T50.912A Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
T50.913A Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, initial encounter
T50.914A Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, initial encounter
T50.915A Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter
T50.991A Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), initial encounter
T50.991D Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), subsequent encounter
T50.992A Poisoning by other drugs, medicaments and biological substances, intentional self-harm, initial encounter
T50.992D Poisoning by other drugs, medicaments and biological substances, intentional self-harm, subsequent encounter
T50.993A Poisoning by other drugs, medicaments and biological substances, assault, initial encounter
T50.993D Poisoning by other drugs, medicaments and biological substances, assault, subsequent encounter
T50.994A Poisoning by other drugs, medicaments and biological substances, undetermined, initial encounter
T50.994D Poisoning by other drugs, medicaments and biological substances, undetermined, subsequent encounter
T50.995A Adverse effect of other drugs, medicaments and biological substances, initial encounter
T50.995D Adverse effect of other drugs, medicaments and biological substances, subsequent encounter
T50.996A Underdosing of other drugs, medicaments and biological substances, initial encounter
T50.996D Underdosing of other drugs, medicaments and biological substances, subsequent encounter
Z71.51 Drug abuse counseling and surveillance of drug abuser
Z79.891 Long term (current) use of opiate analgesic
Z79.899 Other long term (current) drug therapy
Z91.120 Patient's intentional underdosing of medication regimen due to financial hardship
Z91.128 Patient's intentional underdosing of medication regimen for other reason
Z91.130 Patient's unintentional underdosing of medication regimen due to age-related debility
Z91.138 Patient's unintentional underdosing of medication regimen for other reason
Z91.14 Patient's other noncompliance with medication regimen
Z91.19 Patient's noncompliance with other medical treatment and regimen
ICD-10 Codes That Are Not Covered

XX000


Revision History Information
Revision History DateRevision History NumberRevision History Explanation
10/01/2021
R3

Article revised and published on 10/14/2021 effective for dates of service on and after 10/01/2021 to reflect the Annual ICD-10-CM Code Updates.

The following ICD-10-CM codes have been deleted from the ICD-10-CM Group 1 Codes that Support Medical Necessity and therefore have been removed from the article: M54.5, T40.7X1A, T40.7X2A, T40.7X3A, and T40.7X4A. The following ICD-10-CM codes have been deleted from the ICD-10-CM Group 2 Codes that Support Medical Necessity and therefore have been removed from the article: M54.5, T40.7X1A, T40.7X1D, T40.7X2A, T40.7X2D, T40.7X3A, T40.7X3D, T40.7X4A, T40.7X4D, T40.7X5A, T40.7X5D, T40.7X6A, T40.7X6D

The following ICD-10-CM codes have been added to the Group 1 ICD-10-CM Codes that Support Medical Necessity: M54.50, M54.51, M54.59, T40.711A, T40.712A, T40.713A, T40.714A, T40.721A, T40.722A, T40.723A, and T40.724A. The following ICD-10-CM codes have been added to the Group 2 ICD-10-CM Codes that Support Medical Necessity: M54.50, M54.51, M54.59, T40.711A, T40.711D, T40.712A, T40.712D, T40.713A, T40.713D, T40.714A, T40.714D, T40.715A, T40.715D, T40.716A, T40.716D, T40.721A, T40.721D, T40.722A, T40.722D, T40.723A, T40.723D, T40.724A, T40.724D, T40.725A, T40.725D, T40.726A and T40.726D

10/01/2020
R2

Article revised and published on 10/01/2020 effective for dates of service on and after 10/01/2020 to reflect the Annual ICD-10-CM Code Updates. ICD-10 Codes T40.4X1A, T40.4X2A, T40.4X3A, and T40.4X4A were removed and ICD-10 Codes M25.59, T40.491A, T40.492A, T40.493A, and T40.494A were added to the “ICD-10 Codes that Support Medical Necessity/Group 1 Codes:” section of this billing and coding article. ICD-10 Codes T40.4X1A, T40.4X1D, T40.4X2A, T40.4X2D, T40.4X3A, T40.4X3D, T40.4X4A, T40.4X4D, T40.4X5A, T40.4X5D, T40.4X6A, and T40.4X6D were removed and ICD-10 Codes F10.130, F10.131, F10.132, F11.13, F12.13, F13.130, F13.131, F13.132, F14.13, F14.93, F15.13, F19.130, F19.131, F19.132, M25.59, T40.491A, T40.491D, T40.492A, T40.492D, T40.493A, T40.493D, T40.494A, T40.494D, T40.495A, T40.495D, T40.496A, and T40.496D were added to the “ICD-10 Codes that Support Medical Necessity/Group 2 Codes:” section of this billing and coding article. Additional formatting changes have been made throughout the document. The effective date of this revision is based on date of service.

10/01/2019
R1

Article revised and published on 10/17/2019 effective for dates of service on or after 10/01/2019 to reflect the annual ICD-10-CM Code updates. The following codes have been added to Group 1: T50.911A, T50.912A, T50.913A, and T50.914A. The following codes have been added to Group 2: T50.911A, T50.912A, T50.913A, T50.914A, and T50.915A. The following codes have undergone a descriptor change: T40.906A, T40.906D, T40.996A and T40.996D. Asterisks were placed next to the appropriate codes in ICD-10 Code Groups 1 and 2 with the asterisks explanations moved from the Groups paragraph to the asterisks explanations at the bottom of the tables.

Also due to system changes, the coding section of this article has been reorganized and a new section for modifiers has been added.